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CHAPTER I 
INTRODUCTION 
Sialoglycoproteins and the Tumor Cell Surf ace 
Sialoglycoproteins have been implicated in social interactions 
between cells such as contact inhibition of cell growth (Knecht and 
Lipkin, 1977), cell recognition and adhesion (Edwards, 1978), and 
cell aggregation (Kang et al., 1974). Since neoplastic cells are 
considered to exhibit abnormal social interactions (Stoddart, 1979) 
it is not surprising that many reports of qualitative and quantitative 
alterations in cell surf ace sialoglycoproteins resulting from malignant 
transformation of a normal cell have appeared recent.ly (Buck et al., 
1970; Shin et al., 1975; Burridge, 1976; Glick, 1976; Startling et al., 
1978). 
Some reports have indicated that these alterations may be changes 
in the carbohydrate. Many laboratories have noted an increased 
agglutination by lectins of several tumorigenic cells compared to 
agglutination of their normal counterparts (Aub et al., 1965; Nicolson, 
1974; Becker, 1974; and Walborg et al., 1975), alterations in the sizes 
of the oligosaccharides of cellular glycoproteins of t:umorigenic cells 
when compared to their normal counterparts (Warren et al., 1973), 
changes in glycosyl transf erases in some tumors co1npared to normal 
tissues (Patt et al., 1977; Bauer et al., 1977; Bauer et al., 1978), 
and loss of the glycocalyx of highly metastatic ttm10r cells (Kim et al., 
1 
2 
1975). The glycoproteins in some of these studies were characterized 
and found to have oligosaccharides N-linked to asparagine residues. 
Recently, sialomucins, sialoglycoproteins containing alkali-labile 
oligosaccharides 0-linked to serine or threonine residues, have been 
found on the cell surface of many tumor cells. Tumor cell systems in 
which they have been found include ascites mammary adenocarcinomas 
(Codington et al., 1978); Huggins et al., 1980), melanomas (Bhavanandan 
et al., 1977; and Bhavanandan et al., 1981), cultured malignant human 
breast cells (Chandrasekaran et al., 1979), spontaneously and chem-
ically induced rat hepatomas and human colon adenocarcinoma (Price 
and Stoddart, 1976). The Thomsen-Friedenreich antigen (T-antigen), 
which is the disaccharide precursor for mucin sialooligosaccharides, 
has been implicated in some studies in malignant breast lesions 
(Springer et al., 1975 and Springer et al., 1977). The best charac-
terized membrane sialomucin is epiglycanin. This cell surface molecule 
has been found in the TA3-Ha mouse mammary adenocarcinoma and has been 
postulated to be responsible for its allotransplant:ability (Sanford et 
al., 1973). Its structural and functional properties will serve as a 
model system by which other membrane sialomucins can be compared. 
Epiglycanin 
Scanning electron microscopy of whole cells, transmission electron 
microscopy of whole cells treated with polycationic. ferritin (Miller 
et al., 1977), together with electron microscopy of metal-contrasted 
replicas of tryptic fragments of cells (Slayter et al., 1973) suggested 
that epiglycanin is a highly extended rod-shaped sialoglycoprotein 
found in TA3-Ha mouse mammary adenocarcinoma. The f·ibrillar rods 
extend 200-300 nm into the extracellular fluid surrounding a cell. 
Epiglycanin, isolated from whole cells by tryptic digestion and 
gel filtration (Codington et al., 1972), has been analyzed for its 
carbohydrate composition and amino acid composition (Codington et al., 
1978). The major monosaccharides found were galactose, N-acetyl-
glucosamine, N-acetylgalactosamine, and N-acetyl neuraminic acid. The 
most prominent amino acids found were serine and threonine. These 
compositional data indicate that epiglycanin is a mucin-type sialo-
glycoprotein. Physicochemical studies have shm·m t:hat more than 500 
carbohydrate chains are attached to a single polypeptide chain of 
about 1300 amino acid residues in a molecule of about 500,000 
molecular weight. 
Partial characterization of the 0-linked oligosaccharides of 
epiglycanin has been achieved (Van den Eijnden et al., 1979). Two 
acidic or sialylated and three neutral oligosaccharides were isolated. 
The major neutral oligosaccharide is the Thomsen-Friedenreich 
Bl 3 . 
disaccharide, gal-.--galNacOH, comprising 60% of the carbohydrate 
chains. The two sialylated saccharides accounted for only 18% of the 
chains. The major sialylated chain, 13% of the chains, has the 
following structure: 
2 3 Bl 3 NANA--gal--galNacOH 
the same trisaccharide found in fetuin (Spiro and Bhooyroo, 1974) and 
glycophorin (Thomas and Winzler, 1969). The second sialosaccharide is 
proposed to have the structure: 
3 
4 
2 3 Sl 4 Sl 3 Sl 3 NANA--gal--glcNac--gal--galNac 
1: 
NANA 
Codington et al. (Van den Eijnden et al., 1979) considered this to be 
the most complex sialosaccharide yet found on mammalian membrane 
sialomucin. However, oligosaccharides isolated from canine sub-
maxillary mucin (Lombart et al., 1974), ovarian cyst fluid glycopro-
teins (Kabat et al., 1976), and porcine gastric g.lycoproteins 
(Derevitskaya et al., 1978) have quite similar structures. 
Chandrasekaran and Davidson (Chandrasekaran et al., 1979) have 
reported the presence of a monosialylated pentasaccharide with the 
structure: 
2 3 1 4 1 3 1 3 NANA--gal--glcNac--gal--galNacOH 
in a surface molecule of human B16 melanoma. 
Epiglycanin has been implicated in the transplantability of the 
TA3-Ha adenocarcinoma via a masking phenomena on the surface of the 
cell (Codington et al., 1973 and Sanford et al., 1973). The physical 
characteristics of epiglycanin are ideally suited for such a masking 
phenomena. Structural features of epiglycanin responsible for 
transplantability have not yet been identified but since another 
subline which is not transplantable does not contain cell surface 
epiglycanin they suggest that the presence of this sialomucin is at 
least partly responsible for its transplantability properties. 
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ASGP-1 
Recently Sherblom et al. (1980a) have reported the presence 
of a mucin type ascites sialoglycoprotein, ASGP-1, on the surface 
of a transplantable rat mammary adenocarcinoma. Unlike the 
mouse mammary adenocarcinoma studied by c·odington, the glycoprotein 
is also present on a non-transplantable cell line. This suggests that 
more subtle differences in glycoprotein structure may be important in 
the transplantation phenomena exhibited. 
The 13762 rat mammary adenocarcinoma is a dimethyl benzanthrene 
induced solid tumor. The tumor was adapted for ascites growth at 
Mason Research Institute. Three sublines: MAT-A, MAT-B, and_MAT-C 
were isolated (Segaloff, 1966). In addition, a cell culture line, 
MR, was derived from the }L~T-B ascites line by growth in soft agar. 
After a few months of passages in Dr. Carraway's laboratory, the 
MAT-B and MAT-C ascites lines became the more stable MAT-Bl and MAT-Cl 
lines. 
By scanning electron microscopy MAT-Cl cells exhibit a highly 
irregular surface, covered with microvilli extending as branched 
structures from the cell body. MAT-Bl cells have a more normal 
appearance, with unbranched microvilli, ruffles, ridges and blebs 
associated closely with the cell body (Carraway et al., 1978). The 
MAT-Cl subline has been shown to be xenotransplantable into mice 
while the MAT-Bl subline is not xenotransplantable. Both sublines 
contain a major sialoglycoprotein (ASGP-1) which exhibits low electro-
phoretic mobility in SDS polyacrylamide gels. ASGP-1 has been 
purified from membrane vesicles by extraction with 4 M guanidine 
hydrochloride (Sherblom et al., 1980a). The composition of ASGP-1 
from each subline is high in serine, threonine, galactosamine, 
glucosamine, galactose, sialic acid, and fucose with a carbohydrate 
content of 67% and 73% for MAT-Bl and MAT-Cl, respectively. Amino 
acid compositions of ASGP-1 from the two sublines are essentially 
the same. The major differences between them is a three-fold greater 
content of sialic acid per unit protein for MAT-Cl ASGP-1 than MAT-Bl 
ASGP-1 and the presence of sulfated carbohydrate in MAT-Bl ASGP-1 but 
not in MAT-Cl ASGP-1. Molecular weights of 570,000 (MAT-Bl) and 
690,000. (MAT-Cl) were estimated by sedimentation velocity analysis 
and gel filtration in 4 M guanidine hydrochloride. Fractionation of 
oligosaccharides from alkaline borohydride treated ASGP-1 on Bio-gel 
P4 gives patterns that are quantitatively different for MAT-Bl and 
MAT-Cl. This suggests that the differences in oligosaccharide compo-
sition may be a factor involved in the transplantation phenomena 
exhibited by these cells. 
6 
The expression of ASGP-1 appears to be modulated according to the 
environment of growth conditions of the tumor as evidenced by the 
observation that ASGP-1 is present in the ascites cells but virtually 
absent in the solid tumor (Huggins et al., 1980). Furthermore the 
cells, when adapted for cell culture, lose ASGP-1 but upon re-passaging 
in vivo the ASGP-1 abruptly reappears at about the 16th passage (Howard 
et al., 1980). ASGP-1 appears to be shed from the cells by a proteo-
lytic cleavage mechanism into the ascites fluid of the tumor bearing 
animal. The rates of shedding in vitro appear to be the same for the 
MAT-Bl and MAT-Cl sublines. However the amount of ASGP-1 in ascites 
fluid is 80% greater for MAT-Cl cells than for MAT-Bl cells. This 
suggests that other processes beside shedding are involved in deter-
mining the amount of soluble ASGP-1 in ascites fluid for the MAT-Cl 
cells (Howard et al., 1981). Another glycoprotein, ASGP-1, has been 
found to be associated with ASGP-1 in detergent extracts of both cell 
types (Sherblom et al., 1980b). Lectin induced redistribution studies 
indicate that ASGP-1 and ASGP-2 are associated at ·the cell surface 
(Helm et al., 1981). ASGP-2 is believed to play an important role in 
the mechanism by which ASGP-1 is both attached to and shed from the 
ascites cell surface. 
The function of ASGP-1 is still obscure. It is possible that 
7 
it plays some role in the transplantability properties of these cells. 
The role of ASGP-1 in transplantability may partly involve the carbo-
hydrate moiety as well as other factors such as modulation of ASGP-1, 
shedding of ASGP-1, and association of ASGP-2 with ASGP-1. The purpose 
of the studies herein was to investigate structural details of the 
alkali labile oligosaccharides not only to better understand the 
biological function of this major cell surface sialomucin but also 
to gain insight into cell surface sialomucin biosynthesis and its 
control. 
CHAPTER II 
PARTIAL CHARACTERIZATION OF THE GLUGOSAMINE-
CONTAINING 0-LINKED OLIGOSACGHARIDES 
OF ASGP-1 
Introduction 
The 13762 rat mammary adenocarcinoma contains on its surf ace a 
major sialoglycoprotein, ASGP-1 (Sherblom et al., 1980a). The 
expression of ASGP-1 on the cell surface has been shown to be modulated 
in response to environmental stresses (Howard et al., 1980). Evidence 
has been presented to suggest that ASGP-1 may be necessary for the 
existence of the ascites form of the mammary adenocarcinoma. With 
increasing evidence in other systems (Warren et al., 1978) for the 
role of sialoglycoproteins in tumorigenesis it was of interest to 
characterize the oligosaccharide structure of ASGP-1. Preliminary 
data indicated ASGP-1 is a heavily glycosylated (>70% by weight) mucin 
type glycoprotein with sialic acid a prominent component. The presence 
of sialic acid on tumor cell surfaces has been kno"WU for some time 
(Jeanloz et al., 1976). However the isolation and structural charac-
terization of sialoglycoproteins of tumor cells has been reported for 
only one glycoprotein, epiglycanin (Van den Eijnden et al., 1979). 
Once structural features have been defined it may be possible to 
elucidate oligosaccharide biosynthetic principles •~hich may aid in the 
understanding of the cell surface phenomena attributed to glycoproteins. 
8 
Materials 
D-(6-3H) glucosamine (2-6 Ci/mmol), D-(1-14c) glucosamine (56 
mCi/mmol), (3H) NaBH4 (300 mCi/mmol) were from Amersham; Instagel 
was from Packard; CsCl (99.9%) was a product of Varlacoid; guanidine 
hydrochloride (Grade 1) was from Sigma. Carbohydrate standards 
included inositol (Supelco), N-acetylglucosamine, N-acetylgalactos-
amine, arabinose, galactose, N-acetylneuraminic acid, and fucose 
(Sigma). N-acetylgalactosaminitol was prepared by reduction of 
N-acetylgalactosarnine (Laine et al., 1972). a-L-fucosidase from 
bovine epididymis, a-galactosidase from Aspergillus Niger, and 
S-galactosidase (Grade V) from Aspergillus Niger were from Sigma 
and not purified further. 
Methods 
Cells 
MAT-B and MAT-C ascites sublines of the 13762 rat mammary tumor 
were obtained from Mason Research Laboratories and were maintained as 
9 
described previously (Carraway et al., 1976). MAT-Bl and MAT-Cl 
designate the sublines which arose from the MAT-B and MAT-C lines by 
routine weekly passage for one year in Carraway's laboratory (Carraway 
et al., 1978). The distinguishing features of these sublines have 
been stable for over two years since the original observations. Cells 
are passaged by weekly transfers into 2-3 month old female Fischer 344 
rats and maintained as frozen stocks. Cells used for these studies 
were washed three times with cold phosphate buffered saline after 
recovery from the peritoneal cavity. 
10 
MAT cMR6-s is a variant subline originally obtained from the 
MAT-Bl subline. MAT-Bl cells were adapted to cell culture, cloned, 
and after the sixth passage in cell culture re-injected into rats and 
passaged in vivo (Howard et al., 1980). During passage in cell 
culture the cells lost ASGP-1. After the sixteenth passage in vivo 
there was a sudden reappearance of ASGP-1. The Bio-gel P4 chromato-
graphic profile of released oligosaccharitols was similar to the 
profile of MAT-Bl ASGP-1 oligosaccharitols (Figure 1). 
During the passage of MAT-Cl cells the host, Fischer 344 female 
rats, contracted a bacterial infection which quantitatively affected 
the oligosaccharitol content of ASGP-1. These variant cells also 
exhibited a loss of xenotransplantability. This new subline derived 
from MAT-Cl cells was designated MAT-C2. Passage of MAT-C2 cells in 
healthy rats gave rise to another variant cell line after approximately 
25 passages. This variant subline, designated MAT-C3, regained the 
·original oligosaccharitol content of MAT-Cl ASG0-1 but did not regain 
the ability to transplant across species barriers. 
Cell Labeling 
14 3 Radioactive monosaccharides (25 µCi C-gln; 100 µCi H-gln; or 
100 µCi 3H-fuc) in 0.2 ml of 0.9% saline were injected into the peri-
toneal cavity of a tumor-bearing rat 16 hr prior to sacrifice and 
recovery of cells. 
Isolation of ASGP-1 from Membrane Vesicles 
Washed cells were suspended in 10 volumes of lOmM Tris-HCl pH 8.0, 
and allowed to stand on ice for 2 min prior to centrifugation at 600g 
11 
for 2 min. The swollen pellet was suspended in 10 volumes of the same 
buff er and homogenized by four to five strokes of a Dounce homogenizer 
with a tight pestle. Immediately after homogenization the suspension 
2+ + 
was brought to a concentration of 3mM in Mg and lrrc1 in Na by addi-
tion of 30mM MgC12 and lOmM NaCl. The homogenate was centrifuged at 
lOOOg for 1 min and the supernatant was centrifuged at 10,000g for 10 
min. Membrane vesicles were collected by centrifugation of the super-
natant at 100,000g for 90 min. Preformed CsCl gradients were prepared 
by gently layering under each other 2 ml each of 4M Gdn-HCl and lOmM 
Tris-HCl, pH 7.4, containing 1.58, 2.0, 2.37, 2. 79, and 3.15M CsCl in 
5/8 x 3 in centrifuge tubes. Membrane vesicles were suspended in 4M 
Gdn-HCl in lOmM Tris-HCl, pH 8.0 with the aid of a hand homogenizer. 
1 ml (rv5 mg of membrane protein) was layered onto the CsCl gradient 
0 
and the gradients were centrifuged in a Beckman 75 Ti rotor at 4 C for 
16-24 hr at 55,000 rpm. After centrifugation the bottom of the tube 
was punctured using an ISCO f ractionator and 10-20 drop fractions were 
collected. The density of selected fractions was determined by the 
difference in the dry and filled weight of a 25 µl glass constriction 
pipet. Fractions containing radioactivity and eluting at a density of 
1. 38-1. 42 g/ml were pooled and Cs Cl and Gdn-HCl were removed by 
dialysis/concentration with a colloidion bag apparatus. The final 
dialyzate concentrate contained glycoprotein and if not used immediately 
0 it was lyophilized and stored in a screw cap test tube at -20 C. 
Aklaline Borohydride Degradation of ASGP-1 
The glycoprotein in 1.0 ml of distilled water (rv5% by wt. aqueous 
solution) was mixed with 0.5 ml of a standard alkaline borohydride 
solution prepared by dissolving 0.18 gm. of NaBH4 in 1.3 ml of 
distilled water to which 0.26 ml of l.ON NaOH was added. The mixture 
was incubated at 45°C for 16 hrs. After incubation the reaction was 
terminated by the dropwise addition of glacial acetic acid until 
bubbling subsided. The ABH digest was then mixed with 1. 5 ml of a 
suspension of Dowex 50(H+). The suspension was centrifuged at low 
speed and the supernatant saved. The resin was washed three times 
with distilled water. The supernatant and washings were combined, 
lyophilized, and stored at -20°C until fractionated on gel filtration 
media. Oligosaccharides released from the peptide and reduced in 
this manner are referred to as oligosaccharitols. 
Gel Filtration of Oligosaccharitols 
12 
The supernatants and washings from Dowex 50(H+) treatment usually 
in 1. 0-1. 5 ml of distilled water were layered gently onto a 0. 9 x 100 
cm column of Bio-gel P4 (200-400 mesh). The column was eluted with 
O.lM pyridine acetate pH 6.0 and 45 drop fractions were collected using 
a Gilson microfractionator. Appropriate aliquots of selected fractions 
were mixed with two to· four ml of Insta-gel and analyzed for radio-
activity using an LKB 1212 Rack Beta scintillation counter. Fractions 
containing radioactivity were pooled, frozen, lyophilized, and stored 
at -zo0 c until further analyzed. 
DEAE-Sephadex Ion Exchange Chromatography 
of Oligosaccharitols 
Oligosaccharitol fractions from Bio-gel P4 gel filtration chroma-
tography in 1. 0-3. 0 ml of distilled water were applied to a 2. 0 x 30 cm 
13 
column of DEAE-Sephadex A-25 (Sigma). The column was first eluted 
with 0.05M pyridine acetate pH 5.0 and 120 drop fractions were 
collected. After ten to fifteen fractions the column was then eluted 
with a linear gradient of 0.05 to 0.65M pyridine acetate pH 5.0 formed 
by gradual mixing of 120 ml of each pyridine acetate solution. 120 
drop fractions were collected and appropriate aliquots of selected 
fractions were assayed for radioactivity. Pyridine acetate concen-
trations of pooled fractions were estimated by comparison with the 
conductivity of standard pyridine acetate solutions. Pooled fractions 
were lyophilized and stored at -20°c. 
Carbohydrate Analysis 
Oligosaccharitol compositions were determined by GLC of trimethyl-
silyl derivatives or by GLC of alditol acetates. GLC of trimethylsilyl 
derivatives was done essentially as described by Reinhold (Reinhold, 
1972). Aliquots of oligosaccharitols were lyophilized in borosilicate 
ampoules and hydrolyzed with 0.5 ml of 0.5M methanolic HCl for 16 hr 
0 
at 65 C under N2 . Re-acetylation with acetic anhydride, de-0-acetyla--
tion with methanolic HCl, trimethylsilyl derivatization, extraction 
with hexane, and gas liquid chromatography were performed with inositol 
or perseitol as the internal standard. 
GLC of the alditol acetate derivatives was done essentially as 
described by Griggs (Griggs et al., 1971). Aliquots of oligosaccha-
ritols in borosilicate ampoules were hydrolyzed with aqueous 4N HCl 
0 for four hrs at 100 C. After reduction with NaBH4 and acetylation 
with acetic anhydride the alditol acetates were analyzed by GLC. 
Gas chromatography was on 3% ECNSS on Gas Chrom-Q in 6 ft glass columns 
using a temperature program of I40-200°c at 4°C/min. 
Mild Acid Hydrolysis of Sialic Acid-Containing 
Oligosaccharitols 
Oligosaccharitol fractions purified by sequential Bio-gel P4 
chromatography and DEAE-Sephadex chromatography and dissolved in 
distilled water were mixed with an equal volume of O.IN H2so4 and 
incubated at 80°c for I hr. After incubation the reactants were 
cooled to room temperature and neutralized with dropwise addition 
I4 
of I.ON NaOH. The mild acid hydrolyzate was percolated over a Dowex-I 
(formate) resin of I cm height in a pasteur pipette. The column was 
washed with five volumes of water. The eluant and washings contain 
the desialylated oligosaccharitol. The column was then eluted with 
five column volumes of either 0.3N formic acid or I.OM pyridine 
acetate pH 6.0 to recover the released sialic acid. The desialylated 
neutral fraction was rechromatographed over Bio-gel P4 to desalt the 
solution as well as monitor the integrity of the acid treatment. 
GC-MS Linkage Analysis 
Partially methylated alditol acetates were prepared from oligo-
saccharitols by sequential methylation, hydrolysis, reduction with 
sodium borodeuteride, and acetylation as described by Bjorndal 
(Bjorndal et al., I970) and Stellner (Stellner et al., I973) except 
that chemical ionization and methane were used with mass fragmentography 
(Hancock et al., I976; Laine et al., I977; and McNeil et al., I977) of 
the (MH-60) ion to generate a profile of the partially methylated 
alditol acetates. Gas chromatography was on Snpelcoport I00/120, with 
helium carrier gas at 35 ml/min, using a program.~ed temperature 
gradient from 155° to 240°c at 4°C/min with injectors and transfer 
lines at 250°C. The instrument used was a Finnigan 3300-6110, with 
1 Torr methane pressure in the ion source. Ionizing electron energy 
0 
was 150 eV and source temperature was 80 C. Spectra were scanned 
from m/z 100 to 450 at a rate of 2 s/scan. 
S-Elimination of ASGP-1 in the Presence 
3 
of H-NaBH4 
The procedure used for S-elimination was essentially that 
described by Aminoff (Aminoff et al., 1981). The lyophilized glyco-
protein was suspended in 40 µl of 0.05N NaOH in a 0.3 ml Reacti-Vial 
(Pierce). 3 10 µl of a standard solution of H-NaBH4 was added and 40 
15 
µl more of 0.05N NaOH was added. A standard solution of 3H-NaBH4 was 
prepared by dissolving 3H-NaBH4 (300 mCi/mmol) in 0.05N NaOH to a 
concentration of 100 mCi/ml and stored dessicated at -20°C. Unlabeled 
NaBH4 was added to bring the concentration of borohydride to l.OM. 
The reaction mixture was incubated at 45°C for 16 hr. The reaction 
was stopped by dilution with an equal volume of water and a few drops 
of glacial acetic acid. Before further analysis the reduced digest 
3 
was lyophilized at least 3 times with water to remove H20. 
Periodate Oxidation of Sialic Acid-Containing 
Oligosaccharitols 
The procedure for periodate oxidation was essentially that 
described by Gathmann (Gathmann et al., 1981). Oligosaccharitols 
0 
were treated with O.lM sodium periodate at 4 C using O.lM sodium 
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acetate buffer, pH 4.5 for 18 hr. After destruction of excess 
periodate by the addition of glycerol the oxidized oligosaccharitols 
were separated into neutral and anionic components by passage through 
a small column (1 ml) of AGl (Cl-) followed by elution with 0.5M 
pyridine acetate pH 5.0 to elute the anionic components from the 
resin. 
HPLC of Oligosaccharitols 
Oligosaccharitols were dissolved in 50-200 µl of distilled water. 
10-50 µl of sample containing at least 3,000 dpm was injected onto a 
column (0. 4 x 25 cm) of 5 µ silica gel modified with 1,4 diaminobutane 
and equilibrated with 70% CH3CN in 0.05% w/v 1,4 diaminobutane. The 
system used was a Waters M6000 pump with an automatic sample injector 
WISP 710 B, data module, and system controller. The column was eluted 
with the equilibration buffer at a flow rate of 1.0 ml/min. 1.0 ml 
fractions were collected. The column was routinely calibrated with a 
maltodextrin mixture. 
Exoglycosidase Treatments 
a-Fucosidase digestions were done in 50mM sodium citrate pH 5.0. 
a($)-Galactosidase digestions were done in 50mM sodium citrate pH 4.5. 
0.01-0.l unit of the enzymes were added to oligosaccharitol in 100 
0 µl of the appropriate buffer and incubated for 1 hr to 3 days at 37 C 
under a toluene atmosphere. The digestion was terminated by heating 
for 3 min at l00°C. The digest was desalted by passage through an 
ion exchange column (pasteur pipette) consisting of 0.15 ml of Dowex-1 
+ (formate) on the bottom and 0.15 ml of Dowex 50(H ) on the top. The 
17 
column was then eluted successively with 0.5 ml H2o and 0.5 ml 
absolute methanol. The eluant and washings were evaporated in a 
vacuum dessicator and the residue brought up in an appropriate volume 
in preparation for HPLC analysis. 
Analytical Methods 
Protein content was analyzed by the method of Lowry (Lowry et al., 
1951). Hexose was measured by the anthrone assay (Kabat and Mayers, 
1961). Sialic acid was measured colorimetrically by the TBA method as 
described by Warren (Warren, 1959). TCA precipitable radioactivity of 
biological samples was measured in the following way. 10 µl aliquots 
of sample were spotted on Whatman filter paper (3MM), dried in a 60°c 
oven, washed with ice cold 10% w/v trichloroacetic acid for 15 minutes, 
5% trichloroacetic acid for 15 minutes, 1:1 v/v ethanol/water for one 
hour, and 1:1 ethanol/ether v/v for 30 minutes. The filter paper was 
then mixed with two to four ml of Ins ta-gel and analyzed for radioactivity. 
Results 
Isolation of Purified ASGP-1 
T b . h . . d . h 3H 14c 1 · umor earing rats, w en inJ ecte wit or -g ucosamine, 
incorporates greater than 70% of the radioactivity into a component 
which exhibits low electrophoretic mobility in SDS-PAGE (Sherblom 
et al., 1980a). This component has been designated ASGP-1, a major 
ascites sialoglycoprotein on the surface of 13762 rat mammary adeno-
carcinoma. ASGP-1 can be purified from ascites cells by extraction 
from membrane vesicles with 4M Gdn-HCl followed by isopycnic 
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centrifugation in CsCl. ASGP-1 migrates to a density of 1.4 g/ml 
(data not shown) in the CsCl gradient. SDS-PAGE of this fraction 
results in only one radiolabeled component that exhibits low electro-
phoretic mobility. Isolated ASGP-1 represents 0.1% of the total 
cellular protein (Table I) and 0.7% of the total cellular hexose. 
There is a 135-fold purification of ASGP-1 with respect to total 
cellular protein and a 16-fold purification of ASGP-1 with respect 
to total cellular hexose. 9 From 5 x 10 cells 1. 3 mg of ASGP-1 which 
contains 146 µg of hexose can be isolated. The hexose measurement 
is a low estimate of the carbohydrate content since it does not 
account for any of the sialic acid or amino sugars present on 
ASGP-1. 
0-Linked Oligosaccharitols of ASGP-1 
Release of the 0-linked oligosaccharitols of glucosamine labeled 
ASGP-1 was accomplished by alkaline borohydride (ABH) 6-elimination 
under conditions which prevent degradation of the oligosaccharide 
(Carlson et al., 1970). Bio-gel P4 chromatography of the ABH digest 
of MAT-Bl ASGP-1 results in the separation of three major glucosamine-
containing oligosaccharitol fractions designated II, III, and IV 
(Figure 1). Fraction I co-elutes with the void volume and most 
probably represents undigested glycoprotein. The fractions II, III, 
and IV represent 18%, 36% and 36% respectively of the glucosamine 
label. Since glucosamine is metabolized to n-acetyl neuraminic acid 
this quantitation may be misleading. A more accurate quantitation 
was obtained by elimination of the oligosaccharides in the presence 
3 
of H-NaBH4 . This quantitatively labels the reducing end sugar of 
TABLE I 
YIELDS AND SPECIFIC ACTIVITIES OF THE SUBCELLULAR FRACTIONS0 0BTAINED 
DURING ISOLATION OF ASGP-1 FROM 13762 RAT MAMMARY 
ASCITES TUMOR CELLS 
Total Yield;'> Specific Radioactivity 
19 
Fraction 
Protein 
(g) 
Hexose 
(mg) 
P . b. . t rotein asis 
(dpm/µg) 
Hexose basist 
(dpm/µg) 
Cells 1.64 21. 2 2.54 196 
Membranes 0.076 5.0 18.9 288 
ASGP-1 0.0013 0. 146 343 3060 
;-~From 5 x 109 tumor cells. 
t25 µCi/rat of 14c-glucosamine. 
0 ASGP-l was isolated from tumor cells as described in Methods. After 
isolation of each indicated fraction appropriate aliquots were 
analyzed for protein, hexose, and acid-precipitable radioactivity 
as described in Methods. 
Figure 1. Bio-gel P4 Chromatographic Profile of the ABH Digest of 
14c-Glucosamine Labeled MAT-Bl ASGP-1. 14c-gln labeled 
MAT-Bl ASGP-1 was treated with alkaline borohydride, 
desalted on Dowex SO(H ), and chromatographed on Bio-gel 
P4. The column was standardized with A) undegraded 
ASGP-1; B) NANA2gal1galNacOH1; C) NAi'IA1gal igalNacOH1; 
D) gal1galNacOH1, and E) galNacOH. 
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each oligosaccharide chain as it is cleaved from the polypeptide. 
14 Bio-gel P4 chromatography of C-gln ASGP-1 digested with alkali in 
3 the presence of H-NaBH4 is shown in Figure 2. The distribution 
of radioactivity (Table II) indicates that fractions II, III, and IV 
comprise 9%, 27%, and 45%, respectively of the galactosamine. Further 
separation of the gel filtration fractions according to their sialic 
acid content was achieved by anion exchange chromatography. DEAE-
Sephadex chromatography (Figure 3) indicated that MAT-Bl-II consisted 
primarily of a highly anionic fraction designated MAT-Bl-II-3; MAT-Bl-
III primarily contained an intermediate anionic component designated 
MAT-Bl-III-2; and MAT-Bl-IV was comprised solely of a neutral fraction 
designated MAT-Bl-IV-1. From the recovery of 3H-label in each of these 
3 fractions after $-elimination with H-NaBH4 almost half of the glucos-
amine-containing oligosaccharitols released from MAT-Bl ASGP-1 are the 
neutral fraction IV-1 whereas the sialylated saccharitols represent 
35% of the chains released from ASGP-1 by ABH treatment. 
Carbohydrate Composition of II-3, III--2, and IV-1 
The carbohydrate composition of the oligosaccharitol fractions 
II-3, III-2, and IV-1 (Table III) indicated that II-3 and III-2 are 
di-sialylated and mono-sialylated oligosaccharitol fractions. Oligo-
saccharitol fractions III-2 and IV-1 contained small but significant 
amounts of fucose. Since the homogeneity of these fractions is suspect 
definite structural assignments cannot be made but the data indicated 
that each fraction contained at least the tetrasaccharitol sequence, 
Figure 2. Bio-gel P4 Chromato~raphy Profile of 3H-NaBH4 S-Eliminated 
MAT-Bl ASGP-1. 1 C-gln (o~o) labeled MAT-Bl ASGP-1 was 
treated with alkaline borohydride using 3H-NaBH4 (~--e). 
The ABH digest was processed according to the detailed 
procedure given in methods and chromatographed on Bio-gel 
P4. 
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Fraction 
II 
III 
IV 
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TABLE II 
RELATIVE QUANTITATION°0F ABH RELEASED OLIGOSACCHARIDES 
OF MAT-Bl ASGP-1 
% Total Recovery 
GalNacOH GlcNac 
9 18 
27 36 
45 36 
Relative Number of 
Oligosaccharide Chains 
GalNacOH GlcNac 
1 1 
3 2 
5 2 
0 The radioactivity recovered in the Bio-gel P4 fractions II-IV from 
profile of Figure 2 was quantitated and the percentage of label 
recovered in each fraction calculated by comparison to the total label 
recovered in fractions I-IV. The relative number of chains was cal-
culated by setting the fraction II to 1.0. 
Figure 3. DEAE-Sephadex Chromatographic Profiles of the 0-Linked 
Oligosaccharitols of }1AT-Bl ASGP-1. 14c-gln labeled 
oligosaccharitol fractions II-IV as isolated on Bio-gel 
P4 were chromatographed on DEAE-Sephadex as described 
in Methods. 
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TABLE III 
CARBOHYDRATE COMPOSITIONa OF THE OLIGOSAGCHARITOL FRACTIONS 
11-3, 111-2, AND IV-1 
Fraction mole/mole galNacOH 
glcNac gal fuc 
II-3b 0.78 1. 79 
III-2c 0.93 2.0 0.33 
IV-ld 1.16 2.41 0.41 
aDeterrnined as their trimethylsilyl derivatives as described in 
Methods. 
bAverage of four determinations; ranges are glcNac: 0.67-0.92; 
gal: 1.5-2.4; SA: 1.82-2.60. 
c Average of two determinations; ranges are glcNac: 0.76-1.10; gal: 
1.99-2.01; fuc: 0.30-0.37; SA: 0. 71-1.10. 
dAverage of two determinations; ranges are glcNac: 1.16-1.17; gal: 
1.99-2.8; and fuc: 0.28-0.52. 
eAlso determined colorimetrically (Warren, 1959), average of two 
determinations = 2.2, range: 2.0-2.4. 
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The Core Oligosaccharitol(s) of the Oligo-
saccharitol Fractions II-3 and III-2 
The possibility that the three fractions II-3, III-2, and IV-1 
have a common core tetrasaccharitol was initially investigated by 
comparing the de-sialylated core oligosaccharitols II-3D and III-2D 
with the neutral oligosaccharitol fraction IV-1 on Bio-gel P4. 
3 14 H-gln labeled II-3D co-chromatographed with C-gln labeled IV-1 
(Figure 4A) indicated that II-3D eluted at the low molecular weight 
region of IV-1. 3 14 H-gln labeled III-2D co-chromatographed with C~gln 
labeled IV-1 (Figure 4B) indicated that III-2D co-eluted with IV-1. 
This observation prompted an investigation into the further fraction-
ation of the oligosaccharitol fractions II-3D, rn:-2D, and IV-1 by 
HPLC. 
Apparent separation to homogeneity was achieved by elution of 
the aforementioned oligosaccharitol fractions on 5µ silica gel modified 
with 1,4-diaminobutane (Turco, 1981). Comparative HPLC co-elution 
profiles of the fractions are shown in Figure 5. 3 H-gln labeled II-3D 
14 
co-chromatographed with C-gln labeled IV-1 (Figure SA) indicated that 
II-3D consisted of one component oligosaccharitol which co-eluted with 
the smaller of the two components found in IV-1. 3 H-gln labeled 
14 III-2D co-chromatographed with C-gln labeled IV-1 indicated that 
III-2D contained two component oligosaccharitols which co-eluted with 
the two oligosaccharitols of IV-1. 
Carbohydrate Composition of IV-la and IV-le 
Comparative HPLC co-elution profiles (Figure 5) indicated that 
Figure 4. Bio-gel P4 Co-elution Profiles of the Core Oligosaccharitol 
Fractions of II-3 and III-2 with the Neutral Oligosaccha-
ritol Fraction rv14. (A) Co-elution of 3H-gln labeled 
II-3D (o~o) and C-gln labeled IV-1 (o--o), 3H-gln 
labeled II-3 (o~o) was also eluted as an internal 
standard. (B) Co-elution of 3H-gln labeled III-2D (o~o) 
and 14c-gln labeled IV-1 (o--o), III-2 labeled with 
3H-gln (o~o) was also eluted as an internal standard. 
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Figure 5. HPLC Co-elution Profiles of the Core Oligosaccharitol 
Fractions of II-3 and III-2 with the Neutral Oligosaccha-
ritol Fraction IV-1. (A) 3H-gln labeled II-3D (-) was 
co-eluted with ll+c-gln labeled IV-1 (---) on 5µ silica 
gel modified with 1,4 di-aminobutane as described in 
Methods. (B) 3H-gln labeled III-2D (-) was co-eluted 
with 14c-gln labeled IV-1 (---)as in (A). The silica 
gel column was calibrated with a maltodextrin mixture. 
M1 = glucose, M2 = maltose, M3 = maltotriose, M4 = malto-
tetrose, Ms = maltopentose. f 1 is some unknown 3H-labeled 
contaminant. 
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II-3D, III-2D, and IV-1 contain a common oligosaccharitol (II-3Da, 
III-2Da, and IV-la) which apparently elutes as a tetrasaccharitol 
and III-2D and IV-1 contain a second common oligosaccharitol (III-2Dc 
and IV-le) which apparently elutes as a pentasaccharitol. 
Since oligosaccharitol fraction IV is more convenient to work 
with the carbohydrate composition of the two components IV-la and 
IV-le isolated by HPLC was analyzed (Table IV). The data indicated 
that IV-la is the tetrasaccharitol, gal2glcNac1 ga1NacOH1 and IV-le 
is the pentasaccharitol, gal3glcNac1 galNacOH1. 
Structure of II-3 
HPLC analysis indicated that II-3D was homogeneous (Figure 5A). 
Carbohydrate compositional analysis indicated that the de-sialylated 
34 
core of II-3 was the tetrasaccharitol gal2glcNac1 galNacOH1 (Table IV) 
and that II-3 results from the transfer of two sialic acid residues 
to this tetrasaccharitol (Table III). The possible structures of a 
core tetrasaccharitol of the proposed composition are: 
I. Gal~GlcNac~Gal~GalNacOH 
II. Gal~GlcNac~GalNacOH 
I 
Gal 
III. Gal~Gal~GlcNac~GalNacOH 
IV. GlcNac~Gal~GalNacOH 
I 
Gal 
V. GlcNac~Gal~Gal~GalNacOH 
VI. Gal~Gal~GalNacOH 
I 
GlcNac 
Fraction 
TABLE IV 
CARBOHYDRATE COMPOSITIONa OF OLIGOSACCHARITOL FRACTIONS 
IV-la AND IV-le 
Relative Molar Ratio 
35 
gal glcNac galNacOH 
IV-la b 1. 98 1.0 
IV-le c 2.82 1.0 
glcNac taken as 1.0. 
aDetermined as their alditol acetates as described in Methods. 
bAverage of two determinations, range: gal: 1. 76-2 .• 21; galNacOH: 
1. 03-1. 08. 
c Average of two determinations, range: gal: 2.69-2.95; galNacOH: 
1.10-1.14. 
1. 06 
1.12 
To determine which of these structures is most likely the 
partially methylated alditol acetates of the intact and de-sialylated 
11-3 core were analyzed by GC-MS. Data for 11-3 was obtained from 
MAT-Cl ASGP-1. Sufficient material for analysis was not obtainable 
from MAT-Bl ASGP-1. Il-3 from MAT-Cl ASGP-1 has identical carbo-
hydrate composition to and co-elutes with MAT-Bl II-3 on Bio-gel P4. 
Il-3D from both sublines co-elute on 5µ silica gel activated with 
1,4-diaminobutane. The GC profiles of II-3 (Figure 6A) and 1I-3D 
(Figure 6B) indicate that both the intact and the de-sialylated 
oligosaccharitol contain three major components. The identification 
of these components was achieved by comparison of retention times 
with standards and the chemical ionization mass fragmentogram which 
generates the characteristic MH, MH-32, and MH-60 mass fragments of 
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the various partially methylated alditol acetates (Laine, 1981). The 
data indicated that 11-3 contained a1 : 3-linked galactose, b1 : 3,6-
linked galNacOH, and c1 : 4-linked glcNac. Il-3D contained a2 : terminal 
galactose, b2 : 3,6-linked galNacOH, and c2 : 4-linked glcNac. Com-
parison of peak areas of the amino sugars suggested that they are 
present in approximately equimolar amounts which is in agreement with 
the carbohydrate composition data. The fact that 3,,6-linked galNacOH 
is present in both II-3 and II-3D suggested that a sialic acid moiety 
is not directly linked to galNacOH. II-3 contained only 3-linked 
galactose whereas II-JD contained only terminal galactose. Thus the 
two sialic acid residues of Il-3 are linked to galactose via a 1+3 
linkage. Only one structure of. those proposed is consistent with the 
GC-MS data for the core 11-3. It's most likely structure is: 
Figure 6. Gas Chromatographic Elution Profiles of the Partially 
Methylated Alditol Acetates of II-3 and II-3D. The 
multiple mass chromatogram of the partially methylated 
alditol acetates of (A) II-3 and (B) II-3D. Data were 
recorded on a Finnigan Model 3300-6110 instrument. Con-
ditions are described in Methods. The ions traced in 
the mass chromatogram are at M/Z 264, 292, 304, and 393. 
The abscissa records the scan number at 2s/scan and the 
ordinate is relative intensity. The identification of 
the peaks are: a1 , 3-linked gal; a2, terminal gal; b1 and 
b2, 3,6-linked galNacOH; c1 and c2, 4-linked glcNac; f1, 
unknown contaminant, mass spectrum shows no significant 
hexose fragments; f2, possible mixture of mono-substi-
tuted and di-substituted glucose probably introduced into 
sample during_ dialysis steps and Sephadex chromatography 
employed during isolation procedures; £3 , a possible side 
product of acetolysis. 
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It follows that the most likely structure for the intact oligosaccha-
ritol II-3 is: 
II-3 1 3 1 4 1 SA--Gal--GlcNac J(6)GalNacOH 
6(3) 
1 
Gal 
3 
1 
SA 
The question remains as to which positions of GalNacOH the galactose 
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and n-acetylglucosamine residues are attached. A tentative assignment 
has been made on the basis of the lectin agglutinability of ASGP-1. 
ASGP-1 has been previously shown to be a peanut agglutinin receptor 
(Huggins et al., 1980). This lectin recognizes the disaccharitol: 
1 3 Gal--GalNacOH 
suggesting that this is an oligosaccharitol present in ASGP-1. 
Sherblom (Sherblom et al., l 980b) found this disaccharitol to be 
present in ASGP-1. It is not detected readily in these studies 
because the tracer used is glucosamine. This disaccharitol has been 
implicated as a biosynthetic precursor in mucin biosynthesis (Springer 
et al., 1976). It seems logical that II-3 and II-3D contain this 
disaccharitol. Thus the linkages to galNacOH are deduced to be: 
II-3 ~GlcNac.!___iGalNacOH 
3 
1 
Gal 
I 
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Heterogeneity of III-2 
HPLC co-elution profiles (Figure SB) indicated that III-2D 
consisted of at least two component oligosaccharit:o1s which are 
chromatographically identical to the two components of the neutral 
oligosaccharitol fraction IV-1. Comparison of the HPLC profiles of 
II-3D and III-2D (Figures SA and SB) indicate that the smaller of the 
two components of III-2D, III-2Da, is the same tet:rasaccharitol found 
in II-3, II-3Da. Carbohydrate compositional analysis (Table III) 
indicated that III-2 contained small significant amounts of fucose. 
HPLC analysis (Figure 7) of metabolically dual labeled 3H-fucose and 
14c-glucosamine III-2D indeed reveals that a fucosylated oligo-
saccharitol, III-2Db, which does not co-elute with either of the 
components, III-2Da and III-2Dc, is present. 
GC-MS Linkage Analysis of III-2 and III-2D 
Although the oligosaccharitol fractions III-2 and its de-sialy-
lated core III-2D consist of at least three oligosaccharitol chains 
the entire fractions as isolated by sequential gel filtration and 
anion exchange chromatography were analyzed by GC-MS in order to 
insure enough material was present. The results are summarized in 
Table V. 
Consistent with the compositional data III-2 and III-2D contain 
equimolar amounts of the amino sugars, 3,6-linked galNacOH and 4-linked 
Figure 7. HPLC Elution Profile of 3H-Fucose and 14c-Glucosamine Dual 
Labeled III-2D. 3H-fucose (•--•) and 14c-gln (o-o) 
III-2D was analyzed on 5µ silica gel as described in 
Methods. Column was calibrated with a maltodextrin 
mixture. 
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TABLE V 
RELATIVE SUGAR CONTENTS OF THE PARTIALLY METHYLATED AlDITOL 
ACETATES OF III-2 AND III-2D0 
Relative Amount 
Component 
III-2 III-2D 
Terminal fucose 0.03 0.14 
Terminal galactose 0.97 1. 7 
2-linked galactose +* +:-'\ 
3-linked galactose 2.2 0.9 
3,6-linked galNacOH 1.0 1.0 
4-linked glcNac 1. 26 0.87 
. *Its presence is suspected, arguments presented in text. 
3,6-linked galNacOH taken as 1.0. 
0 The PMAA derivatives of III-2 and III-2D were prepared and 
analyzed by GC-MS analysis as described in Methods. 
Relative ratios of each derivative were estimated by 
comparing the intensities of m/z 234 (t-fucose), m/z 264 
(t-hexose), m/z 292 (3 linked galactose), rn/z 364 (3,6-
linked galNacOH), and rn/z 393 (4 linked glcNac). Fetuin 
tetrasaccharitol was run as a standard for the identif i-
cation of 3,6-linked galNacOH and an estimation of the 
relative response of 3 linked gal and 3,6-linked galNacOH. 
No response factor was used for terminal fucose and 
terminal galactose. 
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glcNac. The presence of di-substituted galNacOH in both fractions 
indicated that sialic acid is not linked to this sugar. Comparison 
of the 3-linked galactose:3,6-linked galNacOH ratio in III-2 and 
III-2D shows a loss of approximately one 3-linked galactose/3,6-
linked galNacOH after de-sialylation. A similar comparison of the 
terminal galactose:3,6-linked galNacOH shows a concomitant increase 
of one terminal galactose/3,6-linked galNacOH upon de-sialylation. 
This result indicated that the one sialic acid residue of III-2 is 
3-linked to galactose. Interestingly III-2D still contains internal 
3-linked galactose. If this fraction consisted only of the core 
tetrasaccharitol substituted with one sialic acid residue this result 
would be unexpected. This observation may be indicative of a 
galactose residue substituted in the C-3 position present in one or 
both of the oligosaccharitol components III-2Db and/or III-2Dc 
(Figure 7). 
Periodate Oxidation of III-2 
Insight into the site of attachment of the one sialic acid 
residue to each. of its three oligosaccharitol core components can be 
gained by periodate oxidation with subsequent separation of the 
fragments by anion exchange chromatography. Recently, Gathmann 
and associates (Gathmann et al., 1981) have used this methodology 
to verify the position of sialic acid attachment to the core of the 
porcine submaxillary blood group oligosaccharitol: 
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1 6 
NeuGNc--GalNacOH 
3 
1 
Gal 
2 
1 
Fuc 
Periodate oxidation of 3,6-linked oligosaccharitols will result in 
the cleavage of the galNacOH between the C4 and CS bond: 
CH2o 
61 
HOCH 
sj 
HOCH 
41 
HC0-
31 
HCNHAc 
21 
CH20H 
1 
CH 0-
61 2 
HC=O + 
5 
C=O 
41 
HC0-
31 
HCNHAc 
21 
CH20H 
1 
to give two fragments, one which contains the 3-linked branch and 
the other which contains the 6-linked branch. Separation of these 
fragments according to their sialic acid content can be effected by 
3 
anion exchange chromatography. The distribution of H label from 
3 periodate treated H gln labeled 111-2 between the unadsorbed and 
adsorbed fraction after anion exchange chromatography should reveal 
the position of sialic acid in relation to glcNac and thus reveal 
the galactose residue to which it is linked. Two control experiments 
were simultaneously performed with periodate treatment. One portion 
3 0 
of H-gln 111-2 was incubated in buffer for 18 hr at 0 C. This 
control is necessary since it is possible that during the incubation 
45 
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time the acidic environment (pH 4.5 buffer) could cause the cleavage 
of sialic acid. Another control was the treatment of 111-2 with mild 
acid. This treatment will de-sialylate the oligosaccharitol and 
separation of the sialic acid from the core will give an estimate as 
to the amount of the glucosamine label that has metabolized into 
sialic acid. The analysis (Table VI) of the control indicated that 
a minimal amount (15%) of the oligosaccharitol was de-sialylated 
during the incubation in O.lM sodium acetate, pH 4.5 under the 
conditions for periodate oxidation. Analysis of the mild acid 
treated sample indicated that 20-25% of the label was metabolized 
into sialic acid. Analysis of the periodate treated sample gave an 
elution profile identical to the mild acid treated sample indicating 
that the glucosamine label can be separated from the sialic acid. 
This result established that all of the mono-sialylated oligo-
saccharitols of III-2 have the glucosamine and sialic acid in 
different branches of the core and the sialic acid is linked to 
the core tetrasaccharitol as shown below: 
1 4 1 6 Gal--GlcNac--GalNacOH 
3 
1 
Gal 
3 
1 
SA 
Periodate treatment with subsequent anion exchange chromatography of 
the fragments from dual labeled 3H-fucose and 14c-glucosamine III-2 
resulted in the co-elution of 3H and 14c in the unadsorbed fraction 
suggesting that fucose and n-acetylglucosarnine are in the same branch 
TABLE VI 
BEHAVIOR OF 3i1 RADIOACTIVITY AFTER PERIODATE 
OXIDATION OF 3H-GLN III-2° 
Treatment 
Control 
Mild acid 
Periodate 
Control: 
Mild acid: 
Per iodate: 
% Total Gln Recovered 
Unadsorbed Adsorbed 
16 84 
76 24 
78 22 
0 O.lM sodium acetate, pH 4.5, 0 C, 
18 hr. 
0 0.05N H2so4, 80 C, 2 hr. 
O.lM Naro4 in 0.0~ sodium 
acetate, pH 4.5, 0 C, 18 hr. 
o3 H-gln labeled III-2 was treated under the 
three indicated conditions. After each 
treatment the samples were then analyzed by 
anion exchange chromatography and the 
unadsorbed and adsorbed label was quanti-
tated. 
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of the core tetrasaccharitol. 
Structure of III-2a 
HPLC analysis (Figure SA and SB) indicated that III-2Da is 
identical to II-3Da. GC-MS linkage analysis indicated that every 
chain in III-2 contained 3,6-linked galNacOH and 4-linked glcNac. 
Carbohydrate compositional analysis (Table IV) indicated that III-2Da 
was the tetrasaccharitol gal2glcNac 1 galNacOH1• Periodate oxidation 
of III-2 (Table VI) indicated that the one sialic acid residue was 
linked to the galactose which was 3-l:Lnked to galNacOH. The structure 
for III-2a which is consistent with these data is: 
III-2a 1 4 1 6 gal--glcNac--galNacOH 
3 
1 
gal 
3 
2 
SA 
Structure of III-2b 
From the glucosamine label that co-elutes with the fucose label 
on Sµ silica gel (Figure 7) the fucosylated oligosaccharitol III-2b 
is 12% of the total glucosamine recovered in III-2. The limited 
amount of this fucosylated component and its poor separation by HPLC 
made analysis of this oligosaccharitol difficult. Carbohydrate 
analysis (Table III) had shown that there were at least two galactose 
and one N-acetylglucosamine residues/N-acetylgalactosaminitol. This 
suggests that the fucosylated component of III-2 is the product of 
fucosylation of the core tetrasaccharitol. Thus far the only fucose 
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to galactose linkages reported for mucous glycoproteins is al72. The 
evidence for a 2-linked galactose from GC-MS linkage (Table V) analysis 
is weak but there may be two good explanations. First, the fucosy-
lated component is only minor and such a hexose is present in such 
small amounts that it is not easily detectable. Secondly, a small 
peak elutes in the region where 2-linked galactose is expected to 
elute. The positive identification of this peak was hampered not 
only by its low recovery but also by the presence of hexose contamin-
ation possibly introduced into the sample by dialysis and column 
chromatography steps during isolation procedures. Evidence to 
support the contention that III-2Db is the fucosylated derivative 
of the core tetrasaccharitol was obtained from a-fucosidase digestion 
of this component. The experiments described were done on the 
identical component present in the more abundant neutral fraction 
IV-1. The digestion (Figure 8) resulted in the cleavage of 100% of 
the fucose as evidenced by the label eluting in the monosaccharide 
region. After removal of fucose the core tetrasaccharitol, a, was 
retained and the generation of any smaller oligosaccharitols was not 
evident. This result rules out the possibility that the fucosylated 
component could be a structure like: 
Fucal 3 C 4)GlcNac~GalNacOH 
3 
1 
Gal 
The results of the a-fucosidase digestion are consistent with 
the structure: 
Figure 8. Separation of a-Fucosidase Digesti9n Products of IV-la(b) 
on HPLC. 3H-fucose (•--•) and 14C-gln (o~o) IV-la(b) 
was treated with (A) 50mM sodium citrate, pH 5.0 for 48 
hr at 37°C under a toluene atmosphere and (B) 0.1 unit 
of a-fucosidase in 50mM sodium citrate, pH 5.0 for 48 
hr at 37°c under a toluene atmosphere. The digestion 
products were then separated on 5µ silica gel. The 
peaks are defined as: a. core tetrasaccharitol, 
galzglcNac1 galNacOH1 ; b. fucosylated oligosaccharitol 
of unknown composition; fuc: free fucose. 
51 
16 AM1M2 M3 
' ' ' 
8 
12 6 
::c 8 4 a 
~ '11 
N 4 2 • I >C 
0 
.... 0 0 
... 
»IC 0 I 
• 
B ... 
A. 12 ~ Ju.c. 6 ... ca I I .,. I I n 
I I 
I I 
8 ~: 4 
I I 
4 I ~ 2 
+ " 0 •~a~& 0 
0 8 16 24 32 40 48 
TIME, min. 
III-2b 1 4 1 6 gal--glcNac--galNac OH 
2 3 
1 
(j, 
fuc 
1 
gal 
3 
2 
SA 
However the possibility that fucose is linked al~3 to galactose 
cannot be ruled out. 
Structure of III-2c 
From the glucosamine label recovered in III-2Dc (Figure 7) this 
oligosaccharitol is ~40% of the total glucosamine label recovered in 
the oligosaccharitol fraction III-2D. From carbohydrate analysis 
(Table IV) this component is the pentasaccharitol, gal3glcNac1 
galNacOH1. GC-MS linkage analysis of III-2 (Table V) indicated that 
every chain of III-2 contained at least the trisaccharitol, 
glcNac l-6(gal l-3)galNacOH. Linkage analysis of III-2D (Table V) 
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indicated that after de-sialylation there was still 3-linked galactose 
present. From this data and the periodate data (Table VI) the most 
likely structure for III-2c is: 
1 3 1 4 1 6 gal--gal--glcNac--galNacOH 
3 
1 
gal 
3 
2 
SA 
This structure has been found in blood group substances, most recently 
in human cervical mucin (Yurewicz et al., 1981). In this oligo-
saccharitol the gal+gal linkage is al+3 whereas the other galactose 
linkages are Sl+3(4). Confirmatory evidence of this structure and 
the structure of the tetrasaccharitol, III-2Da (II-3Da), was obtained 
from exoglycosidase digestions. Because of its ease of isolation the 
exoglycosidase digestions were performed on the fraction IV-1 which 
has been shown (Figure SA and SB) to have the identical components 
found in II-3D and III-2D. 3H-glucosamine labeled IV-1 was treated 
with a-galactosidase (Figure 9) and the digestion products analyzed 
by HPLC on Sµ silica gel. This treatment resulted in the disappear-
ance of IV-le (III-2Dc) and the retention of IV-la (II-3Da, III-2Da). 
This is consistent with the cleavage of an a-linked galactose 
residue of the pentasaccharitol (below) to produce the core tetra-
saccharitol: 
al-3 1 4 1 6 gal--gal--glcNac--galNacOH 
3 
1 
gal 
a.-galactosidase 
1 4 1 6 gal--glcNac--galNacOH 
3 
1 
gal 
These results further suggest that the remainder of the galactose 
linkages are S-linkages. 
3 . 
H-glucosamine labeled IV-1 was then 
treated with S-galactosidase and a.-galactosidase simultaneously and 
the digestion products separated on Sµ silica gel (Figure 10). 
Conditions were such that complete digestion was not expected. 
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Figure 9. HPLC Elution Profiles of a-Galactosidase Digestion Products 
of IV-1. 3H-gln (o-o) IV-1 was treated with (A) SOmM 
sodium citrate, pH 4.5 for 1 hr at 37°C under a toluene 
atmosphere, and (B) 0.1 unit of a-galactosidase in SOroM 
sodium citrate, pH 4.5 for 1 hr at 37°c under a toluene 
atmosphere. The digestion products were analyzed on 5 µ 
silica gel. 
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Figure 10. HPLC Elution Profiles of a-Galactosidase and $-Galactosi-
dase Digestion Products of IV-1. 3H-gln (o~o) IV-1 was 
treated with (A) 50mM sodium citrate, pH 4.5 for 1 hr at 
37°c under a toluene atmosphere and (B) 0.1 unit of 
$-galactosidase + 0.015 unit of a-galactosidase in 50mM 
sodium citrate, pH 4.5 for 1 hr at 37°C under a toluene 
atmosphere. The digestion products were analyzed on 5 µ 
silica gel. 
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These conditions were employed to minimize the action of a contamin-
ating B-hexosaminidase (<2.0%) in B-galactosidase and to generate all 
the possible digestion products. 5%, 24%, 19%, and 52% of the 
glucosamine label eluted as a tetrasaccharitol, trisaccharitol, 
disaccharitol, and monosaccharide(itol), respectively. The tetra-
saccharitol, D, is presumably the core structure, IV-la (II-3Da, 
III-2Da) resulting from the cleavage of the a-linked galactose 
residue of the pentasaccharitol, IV-le (III-2Dc). The trisaccharitol, 
C, is presumably gal1glcNac1 galNacOH1 which would result from the 
loss of one galactose residue from the tetrasaccharitol, IV-la 
(II-3Da, III-2Da). The disaccharitol, B, is gal1galNacOH1 resulting 
from the loss of glcNac and/or glcNac1 galNacOH1 resulting from the 
loss of two galactose residues from the core tetrasaccharitol. 
Either is likely because from analysis of a glucosamine labeled 
ASGP-1 hydrolyzate on an amino acid analyzer the radioactive label 
was essentially evenly distributed between glucosamine and galactos-
amine. The label eluting in the monosaccharide(itol) region is 
presumably glcNac resulting from the action of the contaminating 
B-hexosaminidase and/or galNacOH resulting from the complete 
digestion of the fraction IV-1. The results of these digestion 
studies indicated that IV-le (III-2Dc) is the a-galactosylated 
product of the core tetrasaccharitol, IV-la (III-2Da) and that the 
linkages of the core tetrasaccharitol are of the 8-conf ormation. 
From gel filtration data, carbohydrate composition, GC-MS linkage 
analysis, HPLC analysis, periodate oxidation studies, and exoglyco-
sidase studies the fraction III-2 was deduced to be a mixture of 
three oligosaccharitols, III-2a, III-2b, and III-2c which represent 
50%, 10%, and 40% of the total glucosamine recovered. 
III-2a: 
III-2b: 
III-2c: 
Bl 4 Bl 6 · gal--glcNac--galNacOH 
3 
1 
s 
gal 
3 
2 
SA 
50% 
81 4 Bl 6 gal--glcNac--galNacOH 
2(3) 3 
1 1 
a B 
fuc gal 
3 
2 10% 
SA 
al 3 Bl 4 Bl 6 gal--gal--glcNac--galNacOH 
3 
1 
8 
gal 
3 
2 
SA 
Heterogeneity of IV-1 
The heterogeneity of IV-1 was studied by HPLC analysis (Turco, 
1981; White 'et al., 1980). 3H-fucose and 14c-glucosamine dual 
labeled IV-1 HPLC elution profile (Figure 11) revealed at least four 
oligosaccharitol chains, two non-fucosylated (IV-la and IV-le) and 
two fucosylated (IV-lb and IV-ld). An attempt to better quantitate 
the components of IV-1 was made by dividing the Bio-gel P4 fraction 
into three components and analyzing each separately by HPLC. The 
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Figure 11. HPLC Elution Profile of IV-1. Dual labeled 3H-fucose 
(•--•) and 14c-gln (o~o) IV-1 was analyzed on 5 µ silica 
gel modified with 1,4-diaminobutane as described in 
Methods. 
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three fractions analyzed were IVa (Figure 12A), IV (Figure 12B), and 
IVb (Figure 12C), the high, median, and low molecular weight fractions, 
respectively, of IV-1. Quantitation of the four oligosaccharitols was 
estimated by recovery of glucosamine label and is summarized in Table 
VII. From this experiment it appeared that the nonfucosylated oligo-
saccharitols made up almost 70% of the oligosaccharitols of IV-1. 
GC-MS Linkage Analysis of IV-1 
To obtain linkage information on IV-1, GC-MS analysis of the 
partially methylated alditol acetates was performed. The entire 
fraction from Bio-gel P4 was analyzed to insure that enough material 
was available for analysis. The results are summarized in Table VIII. 
IV-1 contained approximately equimolar amounts of 3,6-linked galNacOH 
and 4-linked glcNac. This fraction contained 2-3 times more terminal 
galactose than internal 3-linked galactose. Terminal fucose was 
detected in very small amounts. 2-linked galactose was possibly 
present in small quantities however its precise identification was 
hampered by its low recovery. The low recovery of fucose could be 
indicative of a small amount of fucosylated oligosaccharitols in IV-1. 
Thus all indications are that IV-1 is a heterogeneous fraction in 
which all chains contain at least the trisaccharitol glcNacl-6(gal 1-3)-
galNacOH to which galactose and fucose are variously substituted. 
Structure of IV-la 
Comparative HPLC profiles (Figure 5) indicated that IV-la and 
II-3D are chromatographically identical. Carbohydrate composition 
(Table IV) indicated that IV-la is the tetrasaccharitol, gal2glcNac1-
Figure 12. HPLC Elution Profiles of the Sub-fractions of IV-1. 3H-
fucose (•--•) and 14c-gln (o-o) IV-1 was sub-fractionated 
into (A) IVa, the high molecular weight sub-fraction of 
IV-1 from Bio-gel P4, (B) IV, the medium molecular weight 
fraction of IV-1 from Bio-gel P4, and (C) IVb, the low 
molecular weight fraction of IV-1 from Bio-gel P4 and 
subsequently analyzed by HPLC on 5 µ silica gel modified 
with 1,4-diaminobutane as described in Methods. 
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TABLE VII 
RECOVERY AND RELATIVE AMOUNTS OF THE FOUR 
OLIGOSACCHARITOLS OF IV-1 
Fraction % GlcNac Recovered 0 Relative Ratio 
IV-la 35 2.7 
IV-lb 13 l 
IV-le 33 2.5 
IV-ld 18 1. 4 
0 Radioactive counts in each fraction were quanti-
tated and compared to the total (all fractions) 
recovered. 
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TABLE VIII 
THE PARTIALLY METHYLATED ALDITOL ACETATES OF IV-1° 
Component Relative Amount 
Terminal fucose 0.17 
Terminal galactose 1.48 
3-linked galactose 0.53 
2-liriked galactose +* 
3,6-linked galNacOH 1.0 
4-linked glcNac 0.87 
*Its presence is suspected, arguments presented 
in text. 3,6-galNacOH taken as 1.0. 
0 Analysis by GC-MS and comparison to standards 
was done as described in legend to Table V. 
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galNacOH1• GC-MS data (Table VIII) indicated that every chain in the 
fraction IV-1 contained 3,6-linked galNacOH and 4-linked glcNac. 
These data are consistent with the contention that IV-la has the 
identical structure proposed earlier for Il-3D and III-2Da. 
Structure of IV-le 
Carbohydrate compositional analysis (Table IV) indicated that 
IV-le was the pentasaccharitol, gal3glcNac1galNacOH1 . Digestion of 
the fraction IV-1 with a.-galactosidase (Figure 9) indicated that the 
third galactose residue of IV-le is a-linked to the tetrasaccharitol 
IV-la. HPLC co-elution (Figure 5) indicated that IV-le is chromato-
graphically identical to III-2Dc. From these arguments it follows 
that IV-le has the structure identical to III-2Dc. 
Structure of the Fucosylated Oligosaccharitols, 
IV-lb and IV-ld 
The fucosylated oligosaccharitols were available only in limited 
amounts for structural analysis. For this reason structural infor-
mation has been deduced from experiments with the complete fraction 
IV-1 rather than the individual components separated on silica gel. 
3 14 
a.-Fucosidase treatment of H-fucose and C-gln dual labeled IV-1 
resulted in a 95% release of the fucose as monitored by HPLC analysis 
(data not shown). This suggested that the fucose linkage to the 
saccharide is an a-linkage. Comparison of the de-sialylated core 
oligosaccharitol fraction III-2 with IV-I by HPLC on 5 µ silica gel 
(compare Figure 7 with Figure 11) suggested that IV-lb is identical 
to III-2Db. Thus it appears that IV-lb is simply the core tetra-
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saccharitol fucosylated at one of the galactose residues. On the 
basis of periodate oxidation studies of III-2 described previously 
the galactose linked 1+4 to glcNac is fucosylated. It follows from 
these arguments for IV-lb that IV-ld is the fucosylated product of 
IV-le. Further evidence that these fractions are the fucosylated 
products of IV-la and IV-le was obtained from degradation studies. 
0 IV-1 treated with 0.05N H2so4 at 100 C for two hours, conditions 
shown by other workers (Kobata et al., 1978) to preferentially remove 
fucose, resulted in the retention of the non-fucosylated components 
IV-la and IV-le without any evidence for the generation of any smaller 
oligosaccharitols (Figure 13). Treatment with a-fucosidase gave 
similar results. From these experiments a tentative assignment of 
structure for the fucosylated oligosaccharitols of IV-1 are: 
IV-lb: 
IV-Id: 
Fuc-a-1 ~2-(~3~)Gal~GlcNac~GalNacOH 
3 
1 
Gal 
13 14 16 J Ga --Ga1-. -c1cNac--GaracoH 
Gal 
Fuca.1-2 (3) 
The most likely structure for IV-Id is: 
1 3 1 4 1 6 Gal--Gal--GlcNac--GalNacOH 
2(3) 3 
1 
Fuc 
1 
Gal 
a-Galactosidase treatment of glucosamine labeled IV-1 (Figure 9) 
Figure 13. HPLC Elution Profile of IV-1 Treated with Mild Acid Under 
Conditions Which Preferentially Cleave Fucose Residues. 
3H-Fucose (•--•) and 14c-gln (o~o) dual labeled IV-1 
was treated with mild acid (O.OSN H2so4 , l00°C, 2 hr), 
desalted as described in Methods and analyzed on 5 µ 
silica gel. 
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resulted in the complete disappearance of the IV-le and IV-ld with 
the retention of IV-la and IV-lb. This would be consistent with the 
proposed structure of IV-ld since loss of one galactose residue would 
convert IV-ld into IV-lb: 
IV-ld: Gal--Gal--GlcNac--GalNacOH 
I I 
Fuc Gal 
l a-galactosidase 
Gal--GlcNac--GalNacOH 
I I 
Fuc Gal 
Discussion 
From the data accumulated, ASGP-1 contains eight glucosamine-
containing oligosaccharitols, four acidic (Figure 14) and four neutral 
(Figure 15). It appears that the sialylated oligosaccharitols of 
ASGP-1, II-3, III-2a, II1-2b, and IlI-2c, have a common biosynthetic 
precursor core tetrasaccharitol galBl-4glcNacBl-6 (galS1-3)galNacOH. 
This biosynthetic precursor has been previously isolated from human 
ovarian cyst blood group substance (Rovis et al., 1973), human gastric 
mucin (Oates et al., 1974), desialylated ovine colostrum casein 
(Soulier et al., 1980), human cervical mucin (Yurewicz et al., 1981), 
and the ascites hepatoma, AH 66 (Funakoshi et al., 1982). Il-3 and the 
major fraction of 111-2 were established to be the di-sialo and mono-sialo 
adducts, respectively of the core tetrasaccharitol. This is an interesting 
finding in that very few oligosaccharitols with the glcNac 1-6(ga1Bl-3) 
galNacOH sequence have been found to be sialylated. Williams and 
associates (Williams et al., 1980) speculated that this sequence 
Figure 14. Proposed Structures of the Sialic Acid Containing Oligo-
saccharitols of ASGP-1. 
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II-3: 3 Bl 4 Bl 6 SA--gal--glcNAc--galNAcOH 
13 
I~ 
gi; 9% 
SA 
III-2a: Bl 4 Bl 6 gal--glcNAc--galNAcOH 
3 
1 
B 
gal 13% 
\3 
SA 
III-2b: Bl 4 Bl 6 gal--glcNAc--galNAcOH 
2(3) 3 
1 1 
a. B 
fuc gal 3% 
13 
SA 
III-2c: al 3 Bl 4 Bl 6 gal--gal--glcNAc--galNAcOH 
3 
1 
e 
gal 10% 
t3 
SA 
Figure 15. Proposed Structures of the Neutral Oligosaccharitols of 
ASGP-1. 
IV-la: 
IV-lb: 
IV-le: 
IV-ld: 
rn 4 81 6 gal--glcNAc--galNAcOH 
3 
1 
8 
gal 
81 4 fH 6 gal--glcNAc--galNAcOH 
2(3) 3 
1 
a 
fuc 
1 
B 
gal 
al 3 Bl 4 Bl 6 gal--gal--glcNAc--galNAcOH 
3 
1 
13 
gal 
al 3 81 4 Bl 6 gal--gal--glcNAc--galNAcOH 
2 3 
1 
a 
fuc 
1 
13 
gal 
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17% 
6% 
17% 
10% 
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signaled the mucin biosynthetic machinery to synthesize a neutral 
oligosaccharitol. The only other mucins to my knowledge that contain 
such sialic acid containing oligosaccharitols are surf ace glycopeptides 
of the ascites hepatoma, AR 66, characterized by Funakoshi (Funakoshi 
et al., 1982) and human cervical mucin recently characterized by 
Yurewicz and colleagues (Yurewicz et al., 1981}. Yurewicz reported 
the presence of the mono-sialylated derivative of t:he core tetra-
saccharitol. The disialohexasaccharitol, II-3, and the monosialo-
pentasaccharitol, III-2a, are found in glycopeptides isolated from 
the ascites hepatoma, AH 66. It appears then that t:he theory put 
forth by Williams is not applicable to the assembly of all mucous-like 
glycoproteins. An alternative explanation is that the core tetra-
saccharitol is sialylated in some early step soon after the assembly 
of the neutral tetrasaccharitol. At a later stage during oligo-
saccharitol assembly some regulatory mechanism, possibly in the form 
of a neuraminidase activity, is turned on or off depending on a 
number of factors including substrate availability, intracellular 
pool concentration, or pH. In the case of ASGP-1 t:be regulatory 
mechanism may not be as effective as in other mucins and thus the 
sialic acid would not be removed from ASGP-1 as readily as from 
other mucous glycoproteins .. 
The amount of fucosylated oligosaccharitols of ASGP-1 are 
relatively minimal. From HPLC analysis of ASGP-1 metabolically 
labeled with fucose at least 10% of the oligosaccharitols of III-2 
are fucosylated. Thus ASGP-1 contains some oligosaccharitols with 
both fucose and sialic acid. Such an oligosaccharit:ol has been 
reported only in a few systems, one being porcine submaxillary 
mucin (Carlson, 1968). Dische (Dische, 1963) first observed a 
reciprocal relation between the sialic acid content and fucose 
content of mammalian glycoproteins. An enzymatic basis for this 
observation was described by Beyer (Beyer et al., 1979). Beyer 
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found that only the fucal->-2ga1Sl->-3 (NeuAcal-6) galNac structure could 
be synthesized. The oligosaccharitol III-2b is similar to this 
structure in one respect. The fucose and sialic acid are found in 
separate branches of the structure. It seems tempting to speculate 
that the proximity of a sialic acid to the site of fucose transfer 
may provide an additional means of control. From periodate studies 
it was concluded that fucose and sialic acid are in different 
branches of the core tetrasaccharitol. GC-MS linkage analysis and 
a-fucosidase digestions suggested that fucose is linked al+2 to the 
galactose which is linked 1+4 to glcNac. The absence of any 
fucosylated oligosaccharitol in which the galactose linked 1+3 to 
galNacOH is fucosylated suggests that fucosylation is not a random 
reaction but instead strictly controlled. One control mechanism 
could be manifested in the sialylation of the core tetrasaccharitol. 
Before fucosylation can occur the core must first he sialylated to 
give II-3, de-sialylated to give the mono-sialylated core which is 
then a substrate for a fucosyltransferase. III-2c is a unique 
sialylated oligosaccharitol and has not been reported to my knowledge 
in the literature. It can easily be generated in a similar fashion 
as proposed for III-2b. Instead of the transfer of fucose to 
galactose the transfer of galactose is effected by a galactosyl 
transferase. A galactosyl transferase which catalyzes this transfer 
has been isolated from human plasma (Nagai et al., 1978) and Ehrlich 
ascites tumor cells (Blake et al., 1981). 
The neutral fraction IV-I consists of at least four oligo-
saccharitols. Three of the chains, IV-la, IV-lb, and IV-le, are 
identical to the structures of de-sialylated II-3, III-2a, III-2b, 
and III-2c. IV-ld is a fucosylated component not found in any of 
the other fractions. On the basis of mild acid hydrolysis, 
a-fucosidase digestion, C£-galactosidase digestion, and its elution 
behavior on 5 µ silica gel this oligosaccharitol appears to have a 
structure identical to the B blood group determinant found in the 
blood group substances. This structure was also recently found in 
cervical mucin (Yurewicz et al., 1982). 
Thus it appears that the oligosaccharitols of ASGP-1 are all 
assembled from the core tetrasaccharitol, IV-la. The peripheral 
sugars sialic acid, fucose, and galactose are apparently transferred 
to the core tetrasaccharitol via a complex process that appears to 
be partly controlled since only a few of the possible structures are 
present in detectable amounts. The nature of this complex process 
is the subject of present research efforts. 
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CHAPTER III 
COMPARISON OF THE OLIGOSACCHARITOLS OF ASGP-1 
FROM MAT-Bl AND MAT-Cl ASCITES RAT 
MAMMARY ADENOCARCINOMA CELLS 
Introduction 
MAT-Bl and MAT-Cl ascites tumor cells, variants obtained from 
the 13762 rat mammary adenocarcinoma, have been shown to exhibit 
distinct differences in certain cell surface properties which are 
summarized in Table VIII. It is interesting that the two sublines 
exhibit a difference in transplantability but both contain the major 
cell surface sialoglycoprotein, ASGP-1. Cell surf ace sialoglyco-
proteins have been implicated in transplantation phenomena. The 
allotransplantable mouse mammary adenocarcinoma, TA3-Ha, contains 
a major sialoglycoprotein, epiglycanin, which is not present on the 
non-allotransplantable cell, TA3-St. Codington and his colleagues 
(Codington et al., 1973) have postulated that epiglycanin masks the 
histocompatability antigens on the cell surface. The structural 
detail of such a mechanism has not been elucidated. The presence 
of sialic acid could possibly play a role by creating a negative 
charge on the cell surface that could prevent the approach of any 
circulating antibodies. 
The rat mammary system may provide a system in '~hich structural 
requirements of xenotransplantability can be studied. MAT-Bl and 
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TABLE IX 
CELL SURFACE PROPERTIES OF TWO RAT MAMMARY ASCITES TUMORS 
Property 
Xenotransplantability 
Receptor mobility 
Branched microvilli 
ASGP-1 
Bl 
+ 
+ 
Cl 
+ 
+ 
+ 
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MAT-Cl both contain ASGP-1. The amino acid composition of ASGP-1 is 
similar for both sublines. MAT-Cl ASGP-1 contains at least 2 times 
more sialic acid than MAT-Bl ASGP-1. The oligosaccharitol structure 
of ASGP-1 has been partially characterized (Chapter II). It is of 
interest to compare the oligosaccharitols of MAT-Bl and MAT-Cl ASGP-1 
to determine if any differences in structure can be correlated with 
xenotransplantability. Any differences in structure may provide 
clues to the structure-function relationships of sialoglycoproteins 
involved in transplantation phenomena of tumor cells. In addition, 
differences in structure may provide valuable insights into the 
biosynthetic mechanisms by which mucous membrane glycoproteins are 
glycosylated. 
Materials 
D-(6-3H) glucosamine (2-6Ci/mmole), D-(1-14c) glucosamine 
(56mCi/mmole), and D-(l-3H) fucose (25mCi/mmole) were from Amersham; 
Instagel was from Packard. Silica gel and acetonitrile were from 
Waters Associates. 
Methods 
Xenotransplantation 
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For each tumor line tested, ten C57Bl/6J female mice were injected 
with 0.25 ml of 0.9% NaCl, pH 7.4. Controls were injected with 0.25 
ml saline. Mice were observed for at least 90 days. All other methods 
are as described in Chapter II. 
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Results 
Comparison of the 0-linked Oligosaccharitols 
of MAT-Bl and MAT-Cl ASGP-1 
ASGP-1 from MAT-Cl cells metabolically labeled with 3H-glucosamine 
and ASGP-1 from MAT-Bl cells metabolically labeled with 14c-glucosamine 
were mixed together, treated with alkaline borohydride to release 
0-linked oligosaccharides, and separated by gel filtration on Bio-gel 
P4 (Figure 16). MAT-Bl ASGP-1 and MAT-Cl ASGP-1 contain three major 
glucosamine-containing oligosaccharitol fractions II, III, and IV. 
MAT-Bl-II, MAT-Bl-III, and r1AT-Bl-IV represent 15, 40> and 35%, respec-
tively of the glucosamine label. MAT-Cl-II, MAT-Cl-III, and MAT-Cl-IV 
represent 39, 34, and 10% of the glucosamine label (Table IX). 
Sialylated Oligosaccharitols of MAT-Bl 
and MAT-Cl ASGP-1 
Oligosaccharitol fractions II and III of ASGP-1 have been shown 
by anion exchange chromatography to be sialic acid containing compo-
nents. DEAE-sephadex co-chromatography of MAT-Bl and }1AT-Cl-II 
(Figure 17A) suggested that II from both sublines was disialylated 
and co-chromatography of MAT-Bl and MAT-Cl-III (Figure 17B) suggested 
that III from both sublines is monosialylated. In agreement with 
previous findings (Buck et al., 1980) the gel filtration profile 
(Figure 16) indicated that there was at least two times as much 
disialosaccharitol II in MAT-Cl ASGP-1 as in MAT-Bl ASGP-1. Therefore 
the possibility exists that increased sialic acid content of ASGP-1 
can be correlated with xenotransplantability. 
Figure 16. Bio-gel P4 Elution Profile of the 0-linked Oligosacchari-
tols of MAT-Bl ASGP-1 Chromatographed with MAT-Cl ASGP-1 
0-linked Oligosaccharitols. ASGP-1 from MAT-Cl cells 
a~d MAT-Bl cells metabolically labeled with 3H-gln 
(•--•) and 14c-gln (o~o) respectively was isolated, 
mixed together, treated with alkaline borohydride, and 
eluted on Bio-gel P4 as described in Methods. 
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TABLE X 
RECOVERY OF GLUCOSAMINE LABEL IN THE OLIGOSACCHA."R.ITOL 
FRACTIONS OF MAT-Bl AND MAT-Cl ASGP-1 
% Glucosamine Recovered 0 
Fraction 
MAT-Bl MAT-Cl 
I 8.7 16.3 
II 15.6 39.3 
III 40.5 34.5 
IV 35.0 9.8 
0 Radioactive counts were quantitated for each 
fraction and compared to the total (all fractions) 
recovered. 
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Figure 17. DEAE-Sephadex Elution Profiles of the Sialylated Oligo-
saccharitols of MAT-Bl ASGP-1 Chromatographed Together 
with the Sialylated Oligosaccharitols. of MAT-Cl ASGP-1. 
(A) 3H-gln (•--•) MAT-Cl-II and 14c-gln (o~o) MAT-Bl-II. 
(B) 3H-gln (•--•) MAT-Cl-III and l4c-gln (o~o) 
MAT-Bl-III. 
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Sialylated Oligosaccharitols of MAT-cMR6-s, 
a Variant of MAT-Bl 
MAT-cMR6-s is a variant subline originally obtained from the 
MAT-Bl subline. MAT-Bl cells were adapted to cell culture, cloned, 
and after the sixth passage in cell culture re-injected into rats 
and passaged in vivo (Howard et al., 1980). During passage in cell 
culture the cells lost ASGP-1. After the sixteenth passage in vivo 
there was a sudden reappearance of ASGP-1. The oligosaccharitols of 
ASGP-1 from MAT cMR6-s as separated on Bio-gel P4 (Figure 18) are 
similar to MAT-Bl ASGP-1. Oligosaccharitol fractions II and III 
have apparently shifted to a lower molecular weight (compare Figure 
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16 and Figure 18). This effect arose because of differences in 
protocol. After 8-elimination of the MAT-Bl and MAT-Cl ASGP-1 the 
digest was first desalted with Dowex 50(H+) before elution on Bio-gel 
P4. The desalting step was not used in the analysis of the MAT-cMR6-s 
digest. Without desalting it is possible that the sodium ions present 
mask the negative charge of the sialic acid and thus the sialic acid-
containing oligosaccharitols elute on the column according to their 
size. Desalting the digest removes sodium ions thus exposing the 
negatively charged sialic acid groups. Such negatively charged 
oligosaccharitols have been shown to behave like molecules larger 
than their true size. This effect is termed the charge-exclusion 
effect (Etchison et al., 1977). 
Unlike the MAT-Bl cells, the MAT-cMR6-s cells were xenotrans-
plantable. The ASGP-1 of MAT-cMR6-s has only 15% of the glucosamine 
label associated with the disialosaccharitol fraction II. This 
Figure 18. The Bio-gel P4 Elution Profile of the 0-linked Oligo-
saccharitols Released from MAT-cMR6-s ASGP-1 by ABH 
Treatment. ASGP-1 from MAT-cMR6-s cells was isolated, 
treated with alkaline bor6hydride, and eluted on 
Bio-gel P4 as described in Methods. 
> 
-
• 
E 
"' ... ~ 
"' '----~~~~~--L-~~~-L-~~~-LJ N 
GO 0 
-
H 01 x MlclG 
E Z-
90 
indicated that the increased amount of this oligosaccharitol cannot 
account for the xenotransplantability of the MAT-Cl tumor cells. 
Sialylated Oligosaccharitols of MAT-Cl 
Variant Sublines 
During the passage of MAT-Cl cells the host, Fischer 344 female 
rats, contracted a bacterial infection which affected the pattern of 
oligosaccharitols (Figures 19A, 19B, and 19C) on Bio-gel P4. The 
change from MAT-Cl (Figure 19A) to MAT-C2 (Figure 19B) was accom-
panied by a decreased amount of the oligosaccharitol fraction II. 
Interestingly the change was also accompanied by a loss of xenotrans-
plantability suggesting a correlation with degree of sialylation of 
oligosaccharitols. The rats were quarantined and treated with 
antibiotics. Passage of the MAT-C2 cells were continued in healthy 
animals. Over about 25 passages the ASGP-1 reverted back to an 
oligosaccharitol profile on Bio-gel P4 resembling that of MAT-Cl 
(Figure 19C). The reverted cell line, however, was still found to 
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be nonxenotransplantable. Since it exhibited this difference the new 
subline was designated MAT-C3. MAT-C3 ASGP-1 thus regained the level 
of sialylation found in MAT-Cl ASGP-1 without regaining xenotrans-
plantability. This observation supports the contention that the 
increased sialylation of ASGP-1 cannot account·for the xenotrans-
plantability of the MAT-Cl cells. 
Comparison of the Structures of the Desialylated 
Oligosaccharitols of MAT-Bl and MAT-Cl ASGP-1 
Since the degree of sialylation of oligosaccharitols of ASGP-1 
Figure 19. Bio-gel P4 Elution Profiles of the 0-linked Oligosacchari-
tols of MAT-Cl, MAT-C2, and MAT-C3 ASGP-1. ASGP-1 from 
(A) MAT-Cl cells, (B) MAT-C2 cells, and (C) MAT-C3 cells 
metabolically labeled with 3H-gln (•~•) was treated with 
alkaline borohydride and the resultant digest eluted on 
Bio-gel P4 as described in Methods. 
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did not correlate with xenotransplantability it was of interest to 
compare the desialylated core oligosaccharitols of the two ASGP-1 
molecules to determine a difference, if any, in core structure which 
may be correlated with xenotransplantability. Carbohydrate compo-
sitional analysis suggested that the desialylated core is a tetra-
saccharitol with the composition, ga12glcNac 1galNacOH1. Bio-gel P4 
co-chromatography of desialylated II-3 of MAT-Bl and MAT-Cl ASGP-1 
(Figure 20) indicated that the core oligosaccharitols, II-3D, from 
both sublines are similar in size. The possibility existed that the 
co-eluting peaks may represent oligosaccharitols with identical 
composition but isomeric with respect to spatial arrangement. Further 
analysis of the core oligosaccharitols was performed by HPLC. The 
analysis (Figure 21) indicated that the core oligosaccharitols 
co-elute. Since this chromatographic system is very sensitive to 
branching of oligosaccharitols (Turco, 1981), MAT-Bl and MAT-Cl II-3D 
are identical. 
Bio-gel P4 co-chromatography of MAT-Bl and MAT-Cl III-2 desialy-
lated core (Figure 22) shows that the two core structures, III-2D, are 
similar in size. The broadness of the peak suggested that III-2D is 
heterogeneous. Previous analysis indicated that MAT-Bl III-2D con-
sisted of at least three components, two pentasaccharitols and a 
tetrasaccharitol. HPLC analysis of MAT-Bl and MAT-Cl III-2D (Figure 
23) shows differences in the elution behavior of the two oligo-
saccharitol fractions. MAT-Cl III-2D did not contain appreciable 
amounts of III-2Dc. This component is the pentasaccharitol, 
gal3glcNac1ga1NacOH1 , which results from transfer of one galactose 
to the core tetrasaccharitol. 
Figure 20. Comparison of the Core Oligosacchaiitols of 3H-gln 
(•--•) Labeled MAT-Cl 11-3 and 1 C-gln (o~o) Labeled 
MAT-Bl 11-3 on Bio-gel P4. II-3 from both sublines 
was eluted to serve as an internal standard. 
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Figure 21. HPLC Elution Profile of the Core Oligosaccharitol of MAT-Cl 
II-3 Chromatographed Together with the Core Oligosaccha-
ritol of MAT-Bl II-3. The core oligosaccharitols of 
3H-gln (•--•) labeled MAT-Cl II-3 and 14c-gln (o~o) 
labeled MAT-Bl II-3 were prepared and analyzed by HPLC 
on 5 µ silica gel as described in Methods. 
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Figure 22. Bio-gel P4 Elution Profile of the Core Oligosaccharitol 
Fraction of MAT-Cl III-2 Chromatographed Together with 
the Core Oligosaccharitol Fraction of MAT-Bl III-2. The 
core oligosaccharitol fractions of 3H-gln labeled (•--•) 
MAT-Cl and 14c-gln labeled (o--o) MAT-Bl III-2 were. 
prepared, mixed together, and eluted on Bio-gel P4 as 
described in Methods. III-2 from MAT-Bl and MAT-Cl 
ASGP-1 (first peak) was eluted as an internal standard. 
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Figure 23. HPLC Elution Profile of the Core Oligosaccharitol Fraction 
of MAT-Cl III-2 Chromatographed Together with the Core 
Oligosaccharitol Fraction of MAT-Bl III-2. The oligo-
saccharitol fraction of 3H-gln labeled (~--•) MAT-Cl 
III-2 and 14c-gln labeled (o~o) MAT-Bl III-2 was pre-
pared, mixed together, and analyzed by HPLC on 5 µ 
silica gel. 
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Thus MAT-Cl III-2 was more homogeneous than HAT-Bl III-2 with 
respect to component oligosaccharitols. There was also a difference 
in III-2Da. This peak represents the core tetrasaccharitol and its 
fucosylated derivative. MAT-Cl III-2Da appears to be more heterogen-
eous with respect to component ~..AT-Bl III-2Da. This may represent 
a difference in the amounts of the fucosylated component of III-2 
between the two sublines. This possibility prompted an investigation 
into the fucosylation of MAT-Bl and MAT-Cl ASGP-1. 
Fucosylated Oligosaccharitols of MAT-Bl 
and MAT-Cl ASGP-1 
Fucosylated oligosaccharitols of the two glycoproteins were 
fractionated by gel filtration and anion exchange chromatography of 
3 14 . 
ASGP-1 metabolically labeled with H-fucose and C-glucosamine. 
The separation of oligosaccharitols on Bio-gel P4 is shown for MAT-Bl 
and MAT-Cl ASGP-1 in Figure 24A and 24B, respectively. Each glyco-
protein contains three major fucose-containing fractions III, IV, and 
V. The fucose label elutes at the high molecular weight side of IV 
and V indicating a possible mixture of oligosaccharitols with respect 
to fucosylation. It appears that the major fucosylated oligosacchari-
tol fraction of MAT-Bl ASGP-1 is IV and III is the major fucosylated 
fraction of }fAT-Cl ASGP-1. Characterization of these two fractions by 
anion exchange chromatography and HPLC analysis was undertaken to 
determine the nature of the differences in fucosylation of MAT-Bl and 
MAT-Cl III and IV. 
Figure 24. Bio-gel P4 Elution Profiles of the 0-linke.d Fucosylated 
Oligosaccharitols of MAT-Bl ASGP-1 and MAT-Cl ASGP-1. 
(A) 3H-fucose (•--•) and 14c-gln (o~o) dual labeled 
MAT-Bl ASGP-1 was digested with ABH and the released 
oligosaccharitols were separated on Bio-gel P4 af 4 
described in Methods. {B) 3H-fucose (•--•) and C-gln 
(o~o) dual labeled MAT-Cl ASGP-1 was treated in similar 
fashion as MAT-Bl ASGP-1. 
-2 14 
DPM X 10 C 
GO 
.... 
N 
.... co 0 
___ ... 
-----o...:'"_t(: ~- - = 
J: 
. -·· 
0 
• 0 
.... 
s 
-
_/ 
----~-c. - -·· ~- -
--
---
co ~ 0 GO • 0 
H 01 X IMdO 
£ £-
105 
106 
Fucosylation of MAT-Bl and MAT-Cl Oligo-
saccharitol Fraction III 
DEAE-Sephadex anion exchange chromatography of the dual labeled 
MAT-Bl (Figure 25) and dual labeled MAT-Cl (Figure 26) oligosaccharitols 
indicated that III-2 from both sublines contains fucose. Gel filtration 
comparative profiles indicated that III from MAT-Bl ASGP-1 contains 18% 
(Table XI) of the recovered fucose label whereas III from MAT-Cl ASGP-1 
contains 49% of the recovered fucose label. From this data there is 
apparently a 2-3 fold greater amount of the fucosylated III-2 fraction 
in MAT-Cl ASGP-1 as compared to MAT-Bl ASGP-1. HPLC comparative 
profiles of 3H-fucose and 14c-glucosamine dual labeled III-2D from 
MAT-Bl and MAT-Cl ASGP-1 (Figure 27) indicated that both MAT-Bl III-2 
and MAT-Cl III-2 contain the same fucosylated component, III-2b. 
Therefore the difference in fucosylated III-2 of MAT-Bl and MAT-Cl 
ASGP-1 is quantitative not qualitative. A possible correlation of 
increased amount of fucosylated III-2 with xenotransplantability is 
suggested from these results. It would be interesting to investigate 
this by studying the fucosylation of MAT-C3 ASGP-1. Unfortunately 
this variant subline is no longer available. 
Fucosylation of MAT-Bl and MAT-Cl Oligo-
saccharitol Fraction IV 
From gel filtration analysis oligosaccharitol fraction IV is the 
major fucosylated fraction of MAT-Bl ASGP-1 and the least abundant 
fucosylated fraction of MAT-Cl ASGP-1. The comparison of this 
fraction from the two sublines was made by HPLC on 5µ silica gel 
Figure 25. DEAE-Sephadex Chromatography of 3H-Fucose (tt--•) and 
14c-gln (o~o) Dual Labeled MAT-Bl ASGP-1 Oligosaccha-
ritol Fractions III, IV, and V. Oligosaccharitol 
fractions III, IV, and V from Bio-gel P4 chromatography 
were eluted on DEAE-sephadex as described in Methods. 
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Figure 26. 3 14 DEAE-Sephadex Chromatography of H-Fucose (•~•) and C-
gln (-) Dual Labeled MAT-Cl Oligosaccharitol Fractions 
II, III, IVa, IVb, and V. The oligosaccharitol fractions 
isolated by Bio-gel P4 chromatography were eluted on 
DEAE-sephadex as described in Methods. Fraction IV from 
Bio-gel P4 was pooled into a high molecular weight 
fraction, IVa, and a low molecular weight fraction, 
IVb. Pyridine acetate concentration (---) was monitored 
as described in Methods. 
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TABLE XI 
RECOVERY OF FUCOSE RADIOACTIVE LABEL IN THE OLIGOSACCHARITOL 
FRACTIONS I, III, IV, AND V OF MAT-Bl AND MAT-Cl ASGP-1 
MAT-Bl 
Fraction % Fucose Recovered0 
I 15.3 
III 17.9 
IV 48.1 
v 18. 7 
MAT-Cl 
Fraction % Fucose Recovered0 
I 28.1 
III 43.8 
IV 21. 9 
v 6.2 
0 Radioactive counts in each fraction were quantitated and 
compared to the total (all fractions) counts recovered. 
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Figure 27. 3 14 HPLC Elution Profiles of H-Fucose (•--•) and C-Glucos-
amine (o~o) Dual Labeled MAT~Bl III-2D and MAT-Cl III-2D. 
(A) MAT-Bl III-2D and (B) MAT-Cl III-2D were prepared from 
the oligosaccharitol fraction III-2 and analyzed by HPLC 
on 5µ silica gel as described in Methods. 
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(Figure 28). 
From recovery of glucosamine label, MAT-Cl IV-1 contains the core 
tetrasaccharitol, IV-la, and fucosylated core, IV-lb, in a 40:60 ratio 
whereas these oligosaccharitols are present in an 80:20 ratio in MAT-Cl 
IV-1. MAT-Cl IV-1 does not contain an appreciable amount of IV-le, 
instead it has a small amount of another fucosylated component IV-le. 
It appears that MAT-Cl IV-1 and MAT-Bl IV-1 contain the fucosylated 
component, IV-ld. 
Discussion 
MAT-Cl ascites cells are xenotransplantable into mice but MAT-Bl 
.ascites cells are not. The possible role of ASGP-1 carbohydrate 
structure was investigated by comparison of their oligosaccharitol 
structure and are summarized in Table XII. Gel filtration comparative 
profiles (Figure 16) indicated an increased amount of the disialohexa-
saccharitol 11-3, on the xenotransplantable subline, MAT-Cl. This 
finding was of particular interest since many authors have suspected 
a role for sialic acid in the masking of cell surf ace antigens. This 
had been ascertained by the enhanced antigenicity created by SA 
removal from the cell surface. Many authors have reported the reduced 
transplantability of neuraminidase-treated tumor cells, both in 
allogeneic (Sanford, 1967; Currie, 1967; Currie and Bagshawe, 1968a,b) 
and syngeneic (Simmons et al., 1973; Sethi and Brandis, 1973; Bekesi 
et al., 1971) systems. The mechanism of the role of sialic acid is 
not well understood. Possible explanations are: (1) the sialic acid 
might serve to protect penultimate galactose residues that could serve 
as receptor sites for cytotoxic cells much like they serve as 
Figure 28. HPLC Elution Profiles of 3H-Fucose (•--•) and 14c-Glucos-
amine (o~o) Dual Labeled MAT-Bl IV-1 and MAT-Cl IV-1. 
(A) MAT-Bl IV-1 and (B) MAT-Cl IV-1 were analyzed by 
HPLC on 5µ silica gel as described in Methods. 
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TABLE XII 
SUMMARY OF STRUCTURAL COMPARISON OF MAT-Bl and t1AT-Cl ASGP-1 
Property MAT-Bl ASGP-1 MAT-Cl ASGP-1 
Amount of II-3 + -H++ 
Core tetrasaccharide + + 
Amount of III-2Da + +++ 
Amount of III-2Dc + 
Amount of IV-1 +H+ + 
Amount of Terminal galac.tose ++H+ + 
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receptors for the binding of serum glycoproteins to the liver and other 
organs (Pricer and Ashwell, 1971; Ashwell and :Morell, 1974) and/or 
(2) the loss of sialic acid could lower the negative charge at the 
cell surface, thus increasing the deformability of the cell (Weiss, 
1965) and enhancing its susceptibility to phagocytosis (Lee, 1968). 
If we could correlate the presence of sialic acid with xenotrans-
plantability of MAT cells we might possibly have a system in which 
we could study possible mechanisms for the participation of sialic 
acid in transplantability. However, based on two observations, 
namely that (1) II-3 is present in limited amounts on both a non-
xenotransplantable subline, MAT-Bl, and a xenotransplantable subline, 
MAT cMR6-s and (2) II-3 is present as the major sialylated oligo-
saccharitol on a xenotransplantable subline, MAT-Cl and non-xeno-
transplantable subline, MAT-C3, we conclude that this disialohexa-
saccharitol is not responsible for the xenotransplantability of the 
ascites rat mammary adenocarcinoma. This conclusion agrees with the 
observations of Sanford and Codington (Sanford and Codington, 1971; 
and Sanford et al., 1973). They concluded that the sialic acid of 
epiglycanin, 12% of the carbohydrate content, did not appear to play 
any direct role in the masking process since its removal did not 
significantly alter the adsorption of H-2 antisera. 
Glick and associates (Glick et al., 1978) have noted the peculiar 
properties of fucose and its presence on the surface of tumor cells. 
It has been shown that cancer patients contain high amounts of fucose 
in their serum glycoproteins (Waalkes et al., 1978) probably due to 
the elevated levels of fucosyl transferases (Bauer et al., 1978). 
Evidence has been presented to indicate that the presence of fucose 
at the cell surface (Trefts et al., 1976), more specifically the 
disaccharide sequence fucal-2gal- (Parish et al., 1978) may be 
important for the binding of cytotoxic cells such as B lymphocytes. 
Thus it appears that fucose may play some role in transplantation. 
In the MAT system the non-xenotransplantable and xenotransplantable 
sublines both contain fucosylated oligosaccharitols. The xenotrans-
plantable subline contained approximately two times as much of the 
acidic fucosylated oligosaccharitol, III-2b, as the non-xenotrans-
plantable cell line. The majority of the fucosylated oligosaccha-
ritols of the non-xenotransplantable subline are neutral. These 
observations suggest that the proximity of sialic acid to fucal-2gal 
linkages may prevent the approach and/or binding of circulating 
lymphocytes. However, the fucosylated oligosaccharitols make up at 
the most 19% of the 0-linked oligosaccharitols of ASGP-1. It thus 
seems unlikely that the difference in fucosylation of ASGP-1 could 
be correlated with xenotransplantability. It would be interesting 
to study the fucosylation of cell surface glycoproteins in other 
systems to explore further the possible synergistic role of sialic 
acid and fucose in transplantability. 
119 
Since the presence of terminal galactose has been correlated 
with the increased binding of glycoproteins to liver cells (Ashwell 
and Morell, 1974) it seems possible that terminal galactose may be 
involved in the complex binding processes of transplantation. In 
these studies it is evident that MAT-Bl ASGP-1 had more terminally 
exposed galactose than MAT-Cl ASGP-1. From gel filtration comparisons 
MAT-Bl IV-1 comprised at least 40% of the 0-linked glucosamine-
containing oligosaccharitols of MAT-Bl ASGP-1 compared to only 10% of 
the chains of MAT-Cl ASGP-1. This observation suggested that in the 
MAT system the presence of terminal galactose may be necessary for a 
cell to be recognized by attacking cytotoxic cells. This possibility 
is unlikely since MAT cMR6-s, a variant subline of MAT-Bl, contained 
a similarly high proportion of IV-1 but was found to be xenotrans-
plantable. 
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The fact that ASGP-1 is found on both the xeno- and non-xenotrans-
plantable cell lines coupled with the finding that oligosaccharitol 
structure appears not to be correlated with xenotransplantability 
suggest that ASGP-1 is not directly involved in xenotransplantability 
as epiglycanin is in the TA3 mouse mammary adenocarcinoma. The only 
correlation that has been consistently correlated with transplanta-
bility in the rat mammary adenocarcinoma is a branched cell surface 
morphology (Howard et al., 1982). This does not rule out the· 
possibility that ASGP-1 may be involved in concert with other factors 
to bring about xenotransplantation. The differences in glycoprotein 
structure suggest differences in biosynthetic mechanisms in the two 
cells. These two cell lines may provide a tool for the study of 
mucous glycoprotein synthesis and its control. Future studies will 
be directed towards isolation and characterization of biosynthetic 
precursors of ASGP-1, glycosyl transferases, and glycosyl hydrolases. 
CHAPTER IV 
SUMMARY 
Oligosaccharitols of a major cell surface sia1oglycoprotein, 
ASGP-1, have been isolated by specific alkaline B-e:limination 
from the polypeptide backbone, separation by gel permeation 
chromatography, anion exchange chromatography, and bigh performance 
liquid chromatography. The structural characterization of these 
oligosaccharitols has been accomplished by carbohydrate compo-
sitional analysis, GC-MS linkage analysis, periodate oxidation 
studies, and specific degradation with exoglycos,id.ases. The 
glucosamine-containing oligosaccharitols of ASGP'-l appear to be 
assembled from a core tetrasaccharitol, IV-la: 
IV-la: gal--glcNac--galNacOH 
I 
gal 
This core tetrasaccharitol is variously substituted with sialic 
acid, fucose, and galactose. In MAT-Bl ASGP-1 9% of the glucos-
amine-containing oligosaccharitols result from, the addition of two 
sialic acid residues to the core tetrasaccharitol to give the 
disialohexasaccharitol, 11-3: 
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II-3: 2 3 Bl 4 Bl 6 SA--gal--glcNac--galNacOH 
3 
1 
s 
gl~ 
SA 
This oligosaccharitol is the major carbohydrate chain released from 
MAT-Cl ASGP-1 as at least 30% of the 0-linked chains are disialylated. 
Monosialylated oligosaccharitols comprise 26% of the chains released 
from MAT-Bl ASGP-1. The sialic acid moiety is only found on the 
galactose residue linked 1-)-3 to GalNacOH. One half of the mono-
sialylated oligosaccharitols result from the sialylation of the 
core tetrasaccharitol to give, III-2a: 
III-2a: Bl 4 Bl 6 gal--glcNac--galNacOH 
3 
1 
B 
gal 
3 
SA 
40% of the mono-sialylated chains also contain another galactose 
a-linked to the remaining galactose residue to give III-2c: 
III-2c: al 3 Sl 3 Sl 6 gal--gal--glcNac--galNacOH 
3 
1 
s 
gal 
3 
SA 
The remainder of the mono-sialylated oligosaccharitols of MAT-Bl 
ASGP-1, only 3% of the total, also contain fucose a-linked to the 
remaining galactose residue to give III-2b: 
III-2b: Bl 4 Bl 6 gal--glcNac---galNacOH 
2(3) 3 
1 
a 
fuc 
1 
$ 
gal 
3 
SA 
MAT-Cl ASGP-1 and MAT-Bl ASGP-1 have approximately identical amounts 
of mono-sialylated oligosaccharitols, however, the two glycoprotein 
molecules differ in the amount of III-2b and III-2c present. MAT-Cl 
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ASGP-1 does not have detectable amounts of III-2c and instead has more 
of the fucosylated component, III-2b. It appears from HPLC analysis 
that 60% of the mono-sialylated oligosaccharitols are non-fucosylated 
III-2a and 40%, only 10% of the total carbohydrate chains of MAT-Cl 
ASGP-1, are the fucosylated component, III-2b. The neutral (non-
sialylated) oligosaccharitols of MAT-Bl ASGP-1 represent almost 50% 
of the 0-linked oligosaccharitols. Although the neutral oligo-
saccharitols are isolated in one broad peak on gel filtration media, 
four distinct oligosaccharitol fractions are isolated by high per-
formance adsorption chromatography on 5µ silica gel modified with 
1,4-diaminobutane. 17% of the oligosaccharitols of MAT-Bl ASGP-1 
result from the addition of galactose to the core tetrasaccharitol 
to give IV-le: 
IV-le: al 3 Bl 4 Bl 6 gal--gal--glcNac--galNacOH 
3 
1 
B 
gal 
From exoglycosidase digestions it has been established that this 
galactose is a-linked. 10% of the chains of MAT-Bl ASGP-1 are 
products of the addition of galactose and fucose to the core 
tetrasaccharitol to give IV-ld: 
IV-ld: al 3 Bl 4 81 6 gal--gal--glcNac--galNacOH 
2(3) 3 
1 
a 
fuc 
I 
B 
gal 
6% of the chains result from the fucosylation o.f the core tetra-
saccharitol to give IV-lb: 
IV-lb: B B gal--glcNac--galNacOH 
2 (3) 3 
1 
a 
fuc 
1 
13 
gal 
The remainder of the chains, 17% of the total, are the core tetra-
saccharitol, IV-la. MAT-Cl ASGP-1 differs from }1A.T-Bl ASGP-1 in that 
the neutral fraction IV as isolated from gel filtration represents 
only 9% of the carbohydrate chains. From HPL{; analysis this neutral 
fraction also appears to contain four components, three of which 
co-chromatograph and are identical to IV-la, IV-Ih, and IV-ld of 
MAT-Bl ASGP-1. One fucosylated component of MAT-Cl IV is not found 
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in MAT-Bl ASGP-1. Its low recovery during isolation made its further 
characterization impossible, however it seems reasonable that it is an 
isomeric oligosaccharitol of IV-lb, possibly: 
1 4 1 6 gal~glcNac~ga,!acOH 
gal 
2 (3) 
1 
fuc 
These results suggest that there are only quantitative differences 
in oligosaccharitol content of MAT-Bl and MAT-Cl ASGP-1. It appears 
that none of these differences are directly related to xenotrans-
plantability. It is apparent that ASGP-1 of the xenotransplantable 
MAT-Cl cells contains at least two times as much sialylated oligo-
saccharitol II-3 as MAT-Bl ASGP-1. Its presence however is not 
responsible for transplantation since a variant subline, MAT-cMR6s, 
contains only minimal amounts of II-3 and yet is xenotransplantable. 
Furthermore, another cell line, MAT-C3, was found to be non-xenotrans-
plantable and its major oligosaccharitol is II-3. MAT-Cl ASGP-1 
contains at least two times as much of the f ucosylated mono-sialylated 
oligosaccharitol, III-2b, as MAT-Bl ASGP-1. It is possible that the 
close proximity of fucose and sialic acid may play a role in trans-
plantation. This is unlikely though since this fucosylated oligo-
saccharitol is only a minor fraction, 10% of the oligosaccharitols 
of MAT-Cl ASGP-1. MAT-Bl ASGP-1 appears to contain at least three 
times as much terminal galactose as MAT-Cl ASGP-1. With the known 
binding capacity of terminal galactose (Morell and Ashwell, 1974) it 
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seems possible that such a structural feature could be responsible for 
the decreased transplantability of MAT-Bl cells. This is also unlikely 
since the xenotransplantable cell variant, HAT cMR6-s has ASGP-1 with 
similar amounts of terminal galactose. 
All indications are that the carbohydrate structure of ASGP-1 
does not play any consistent role in xenotransplantation. The MAT rat 
mammary system however may provide an interesting means of studying 
the biosynthetic principles of glycosylation of mucous like membrane 
glycoproteins. This study raises such interesting questions as: 
Why does MAT-Cl ASGP-1 contain more sialylated oligosaccharitols than 
MAT-Bl ASGP-1? Is the addition of sialic acid the final step in the 
assembly of the oligosaccharide or is it an early step after which 
sialidase activities are determining factors in the extent of 
galactosylation and fucosylation of the core tetrasaccharitol? These 
and many more questions can be explored by studying the enzyme levels, 
both glycosyl transferases and glycosyl hydrolases, in the various 
sublines of the 13762 rat mammary adenocarcinoma. 
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